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ABSTRACT 
 
Chapnick, Douglas Andrew (Ph.D., Biochemistry) 
Characterization of the Role of MEK1 Kinase Activity in TGFβ Induced 
Collective Cell Migration 
Thesis directed by Professor Xuedong Liu 
 
 The migration of individual cells and collective groups of cells has been 
repeatedly shown to be an important cellular behavior throughout normal biology 
and disease progression. Although a significant amount of research has been 
conducted to understand how an individual cell achieves migration, relatively 
little is known about how groups of cells coordinate their efforts to migrate 
collectively. Several protein cytokines, including Transforming Growth Factor 
Beta (TGFβ), have been identified that can be globally administered to cells in 
vitro, but yield highly directional collective cell migration. In this thesis, I detail 
my efforts in elucidating how TGFβ stimulation of the human keratinocyte cell 
line, HaCaT, results in directional and collective cell migration.  
I developed an in vitro assay and computational analysis program, named 
Pathfinder, to accurately quantify the angular movements of individual cells in 
time-lapse microscopy videos. This innovative approach allowed me to measure 
the degree to which individual cells turn as they migrate and the degree to which 
neighboring cells adopt the same migration direction. Using my newly developed 
tools to measure cellular migration, I found that TGFβ stimulation of HaCaT cells 
iv 
 
indirectly activates MEK1 kinase activity, which is modulated by ligand induced 
cellular spreading. The resulting MEK1 kinase activity is required and sufficient 
to elicit collective cell migration in a group of physically interacting cells. I also 
showed that such collective cell migration is likely the result of the ability of 
MEK1 kinase activity to suppress turning behavior in individual cells, which 
contributes to the spontaneous induction of collective migration behavior in a 
group of cells. My findings contribute to the TGFβ field by providing an 
explanation for how MEK1 kinase can be activated by TGFβ receptor activation. 
In addition, my findings contribute to the collective cell migration field by 
detailing the important role of MEK1 activity in cellular steering, and providing 
an improved simple model for how collective migration can arise spontaneously.  
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 CHAPTER I 
 
INTRODUCTION 
 
Cellular Migration in Biology 
Throughout each our lives, cells migrate within our bodies, propelling in 
some manner every single biological process. From embryo implantation [1] 
to cancer progression [2-5], individual cells are guided by biochemical and 
physical stimuli [6] that are interpreted by an extremely complex intracellular 
signal transduction network of proteins [1, 3, 4, 7-9]. Additionally, such 
stimuli can come from neighboring cells, resulting in local coordination 
amongst groups of cells in a process termed “collective migration” [10-13]. 
Currently, the cell migration field has identified a plethora of proteins and 
biochemical interactions that comprise the cell motility network, but still has a 
relatively large amount of information to gather before the dynamic flow of 
signal transduction is understood to the point that directional motility behavior 
can be predicted. In this chapter, I will describe how cell migration propels 
biological processes, the current models for individual and collective cell 
migration, and how Transforming Growth Factor Beta (TGFβ) and Mitogen 
Activated Protein Kinase Kinase 1 (MEK1) have been implicated in the 
regulation of cellular migration. Our ultimate challenge in the field of cell 
migration is to understand the structure and dynamics of the cell motility 
protein-protein interaction network for individual cells and groups of cells, so 
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that we may one day be able to completely and efficiently manipulate cell 
migration in order to treat disease and improve the standard of living. 
 
Individual Cell Migration 
Individual cells migrate through a cyclical process of front end extension 
and rear end retraction, which ultimately propels the cell forward [14]. A 
migrating cell exhibits morphological polarization, where the front and rear 
ends do not qualitatively have the same structure when examined under a 
bright-field microscope. The front end of a migrating cell is described either 
as a lamellipodia, when it appears as a broad flat sheet, or a filopodia, when it 
displays abundant spike-like projections [15]. In contrast, the rear of a cell 
frequently appears to be a relatively long tubular structure [1]. Such 
asymmetric cellular structure is supported by an internal asymmetric actin 
cytoskeleton, which is shaped and maintained by polarized biochemical 
activities that control actin polymerization and depolymerization, in a 
spatiotemporal manner [1, 14, 16-21]. Large multiprotein transmembrane 
cellular adhesion complexes (often referred to as focal adhesions) physically 
connect the intracellular actin cytoskeleton to the extracellular matrix upon 
which a cell migrates, resulting in cellular traction [22]. These adhesion 
complexes are spatiotemporally regulated in a similar manner to that of the 
actin cytoskeleton [22-25]. Thus, a critical principle of our current model for 
how an individual cell migrates relies on the coordination of the dynamic 
regulation of both the actin cytoskeleton and the adhesion complexes 
throughout a cell.  
2
 Actin Structure Regulates Front End Protrusion 
At the front end of a cell, whether a lamellipodia or multiple filopodia will 
form is determined by the type of actin cytoskeleton structure that supports the 
plasma membrane. In lamellipodia, the structure of the actin network is highly 
branched [15]. This branching is mediated by Arp2/3 binding to the end and 
internal locations of an actin filament, resulting in the nucleation of an actin 
filament “branch”[15, 26]. The whole branched network is further 
strengthened by filament crosslinking via filamin A and α-actinin [15]. In 
contrast to lamellipodia, filopodia maintain long parallel bundles of actin that 
form as the result of the activation of Ena/VASP proteins, which suppress 
actin capping and Arp2/3 activity [15]. Filopodia bundles are crosslinked 
through the protein fascin, which increases the stability of the filopodia 
structure [27].  
The strength of the actin network in both types of front end structures is an 
important quality that allows for front end protrusion, as the actin network 
must push the plasma membrane forward during this process [1]. However, 
the force to push the plasma membrane forward is thought to be generated 
differently between these two structures. In lamellipodia, the force comes 
from the release of stored elastic energy as actin filaments transition from a 
bent formation to a straight formation [26]. In filopodia, the force comes 
directly and entirely through actin “tread milling”, where filaments merely 
extend the membrane outwards by the addition of actin monomers to the 
barbed end (sub-membrane) and removal of actin monomers at the pointed 
3
end (away from the membrane) [15]. The identification of two types of front 
end protrusion mechanisms suggests that there is at least two distinct modes of 
individual cell motility mechanisms.   
 
The Creation and Destruction of Adhesion Complexes 
As the front end of a cell protrudes, new cellular adhesion complexes are 
formed upon contact of the protruding membrane with the extracellular matrix 
[22]. Exactly how these multiprotein complexes assemble upon contact is less 
understood than their composition and disassembly. Integrin transmembrane 
receptors within adhesion complexes are the proteins that mediate direct 
contact with the extracellular matrix [28-31]. The linkage between actin 
filaments and integrin receptors is achieved through the proteins Talin, 
Tensin, Paxillin, Zyxin and Vinculin, which assemble in a ECM context 
dependent manner [32, 33]. As a cell migrates forward, adhesion complexes 
remain stable, resulting in the localization of older adhesions complexes 
towards the rear of the cell [1]. The formation of adhesion complexes at the 
front of the cell is regulated by Rho GTPase activity [34]. However, the 
mechanistic determinant of exactly where an adhesion complex forms is not 
fully understood.  
Disassembly of adhesion complexes is also incompletely understood, but 
there appears to be three main components to the mechanism of disassembly. 
First, Focal Adhesion Kinase (FAK), Src and Rho GTPase activities all lead to 
increased turnover of adhesion complexes [35, 36]. However, it is not yet 
clear how these disassembly events are spatially activated at some, but not all, 
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adhesion complexes in the cell. Second, the physical tension of actin fibers 
due to actinomyosin contraction at the rear end of the cell has also been shown 
to be sufficient to “tear” the adhesion complex apart [14]. Lastly, such tension 
at the rear end is sufficient to activate stretch-activated calcium channels, 
which leads to Calpain mediate proteolytic cleavage of adhesion proteins [37]. 
The extreme complexity of biochemical activities at adhesion sites and the 
diverse context dependent regulation of adhesion complexes has made the 
studying of these molecular structures difficult. Significant progress on this 
front will require improved assays that can determine the composition of 
adhesion complexes, over time, in live cells, at single site resolution. 
 
Determinants of Cellular Front End Identity 
Front and rear end identities in a cell are determined by the subcellular 
polarization of Rac activity [1]. Rac activity is activated by adhesion complex 
formation at the front end [38], and suppressed by Rho activity elsewhere in 
the cell [21, 39]. At least one Rho subfamily GTPase, CDC42, is seemingly 
always recruited to the front of a migrating cell via the polarization of Rac 
activity [17]. The downstream effectors of Rac/CDC42 activation are the 
WASP/WAVE family of Arp2/3 protein activators [16, 40, 41], which 
explains how Rac activation stimulates lamellipodia formation but not how 
Rac activation stimulates filopodia formation. How the latter is achieved 
remains a mystery in the field.  
CDC42 localization to the front end of a cell is required for maintenance 
of cell polarity and directional migration [17, 18], and the restriction of 
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CDC42 activity to this location prevents lamellipodia formation at other 
locations in the cell [42]. Although the migration field has made significant 
advances in describing the molecular events in a polarized cell, it has not been 
able to fully elucidate the initial molecular or physical determinant for front 
end identity. However, a recent publication has presented a new theory that 
states that the front end of a cell exhibits high membrane tension, compared to 
the rest of the cell [6]. This asymmetric membrane tension can be perturbed in 
capillary pipet based experiments, which results in the disruption of CDC42 
asymmetry in the cell. Thus, it appears that high membrane tension might be 
the absolute initial response of the cell to its environment, which subsequently 
recruits proteins that are observed to be restricted to the front end through an 
unknown molecular mechanism. Future studies that measure and manipulate 
membrane tension will be needed before such a theory is fully accepted by the 
migration field.   
 
Cellular Density Sensing  
Although the biochemical mechanisms behind cellular mechano-sensing 
of their environment are still unclear, the ability of cells to sense neighboring 
cell is not in question. This first described observation of this cellular 
migration behavior, in 1953, showed that chick heart fibroblasts reduced their 
migration speed when in close contact with neighboring cells [43]. Such 
behavior was termed “contact inhibition of locomotion”, and was used to 
explain how wound healing is initiated. The process of contact inhibition of 
locomotion became even more interesting to researchers when it was 
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discovered that malignant transformed cells displayed a reduced ability to 
respond in this manner to neighboring cells [44-46]. However, several decades 
passed with little progress in understanding this mechanism, due to the lack of 
molecular biology and imaging techniques that are required to address this 
problem [47]. More recently, such techniques have been developed, and more 
progress has been made on understanding contact dependent cellular 
migration. For instance, cellular contacts have been repeatedly shown to 
govern cellular polarity and directional migration [48-50]. These recent 
studies have marked a drastic change in the focus of investigations at the 
border of the cellular communication and the cellular migration fields, as 
investigations now seek to understand how cellular communication activates 
migration, rather than inhibits migration. This cellular contact dependent 
coordinated migration behavior of groups of cells is referred to as “collective 
migration”. 
 
Defining Collective Migration 
In the cell migration field, one definition for collective migration that has 
been proposed has three parts: cells are physically linked by strong cell-cell 
interactions, cells migrate in the same direction, and the underlying ECM is 
modified upon migration of the group [3]. In conflict, another definition has 
been set forth that proposes that collective migration is the condition in which 
neighboring cells physically interact and migrate in the same direction [11]. I 
favor the second definition for two reasons. First, in the biological example of 
the rostral migratory stream, neural precursor cells migrate together from the 
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subventricular zone to the olfactory bulb [51, 52]. Although these cells display 
relatively weak cell-cell interactions [11], their shared migration direction is 
clearly observable. As a result, the requirement for strong cell-cell interactions 
does not seem justified in the definition of collective migration. In any case, a 
clear metric for measuring cell-cell contact strength has not been presented in 
the field, and would be required for identifying collective migration according 
to the first definition. Additionally, since ECM modifications occur even in 
the case of individual cell migration [1, 3, 7], ECM modification should not be 
considered in the definition of collective cell migration, as it is a quality of all 
cell migration. Thus, collective migration is more accurately defined as 
physically linked cells that migrate in the same direction. 
 
Collective Cellular Migration in Biology 
  An extreme number of biological processes in nature depend upon the 
collective migration of neighboring cells [51, 53-57]. In slime molds, 
individual cells organize and migrate in a slug formation in order to achieve 
collective translocation of a group of cells that can originate from independent 
spores [9, 58]. In vertebrates, during the gastrulation phase of embryogenesis, 
sheets of cells migrate collectively in order to achieve the invagination of the 
developing embryo [59]. Similarly, epithelial cells collectively migrate in 
sheets during embryonic eyelid closure in mice [57]. Additionally, sheets and 
globular groups of cells have been observed to migrate collectively during 
cancer metastasis [3, 47]. The advantage of such collective behavior is that 
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during migration, tissue organization remains intact, and migration is highly 
directional [3, 4, 11].  
In cancer biology, collective migration aids tissue invasion in the absence 
of epithelial to mesenchymal transition (EMT), which is the known 
mechanism by which cells display loss of cell-cell contacts [60, 61]. In this 
case, the therapeutic application of studying collective migration aims to 
hinder such migration. A theoretical way in which cancer progression is aided 
by collective migration is that individual cells with low proliferative and 
migratory capacity at the site of origin can be brought into another tissue in 
which they would have high proliferative and migratory capacity. In this 
manner, the cells that govern the migration speed and the direction of the 
collective group are not necessarily the same cells that perpetuate cancer 
progression upon metastasis. Since the directional guidance of groups of cells 
during collective migration is recognized as critical for both development and 
cancer progression, it is not surprising that this subject is currently at the 
forefront of the collective migration field.  
 
Leader and Follower Cells in Collective Migration 
During collective migration, not all cells must actively contribute to the 
motility of the group [10, 62, 63].   In some cases, a small subset of cells 
(termed leader cells) is thought to guide the direction of “follower” cells, such 
that the entire group appears to actively migrate in a single well-defined 
direction. The cellular characteristic that identifies a leader cell from a 
follower cell has been proposed to be that leader cell polarity orients towards 
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the migration of the collective group, while follower cell polarity does not 
[62]. However, there is currently only one truly quantitative investigation in 
the literature of leader/follower cell behavior, where the direction and speed of 
each cell within a group were determined as a function of time throughout in 
vitro migrating endothelial sheets [63]. In this investigation, FGF treated 
endothelial sheets composed of HUVEC cells display lamellipodia formation 
in the leading edge cells (those at the wound edge), but not in cells farther 
back in the sheet. As a result, leader cells were identified based on their 
content of lamellipodia, rather than according to the definition presented in the 
field, above. This discrepancy illustrates the lack of a consensus definition of 
leader cell identity, and the requirement of future studies in order to determine 
exactly what the necessary characteristics of leader cells are. Nevertheless, 
using experimental observations and mathematical modeling, the investigators 
concluded that these leader cells pull the follower cells forward and govern 
the direction of the collective group through adhesive cell-cell contact forces. 
Although this study has significantly contributed to our understanding that 
only a few cells can efficiently guide a group of cells in collective migration, 
there are many unanswered questions. For instance, can a filopodia containing 
cell be substituted for a leader cell with lamellipodia? Can all cells actively 
and collectively migrate as the result of other ligand stimulations? If so, how 
do cells without lamellipodia migrate actively in the same direction? Can cells 
migrate collectively in large groups in the absence of a wound? If so, how is 
the direction determined for the group? These answer to these questions are 
not currently known. 
10
 TGFβ Signaling and Cellular Migration 
TGFβ has been implicated in vivo in wound healing [64-66], where upon 
injury to skin, TGFβ secretion coincides with the early stages of tissue repair 
[67]. Additionally, TGFβ mediates the activation of cell migration during 
embryonic eyelid closure and dorsal closure, both of which are developmental 
processes that involve the collective migration of epithelial sheets of cells [56, 
57]. Furthermore, TGFβ signaling has been shown to promote the invasive 
behavior of transformed cells during breast cancer metastasis, where transient 
Smad activation leads to an increased metastatic potential of individual cells, 
but not groups of cells [68]. However, the role of TGFβ signaling in cancer 
related processes that depend upon collective cell migration has not been 
clearly defined.  
 
Signal Transduction in the TGFβ Pathway 
  TGFβ signals through both the canonical and the non-canonical 
pathways. In the canonical pathway, ligand binding to the TGFβ type II 
receptor (TβRII) leads to kinase activation and hetero-oligomerization of 
TβRII with the type I receptor (TβRI) [69]. Trans-phosphorylation of TβRI by 
TβII leads to the activation of TβRI Ser/Thr kinase activity, ultimately leading 
to phosphorylation of receptor regulated Smad proteins (R-Smads), Smad2 
and Smad3, at their respective C-terminal SSXS motifs [70]. Phosphorylated 
R-Smads undergo homo and hetero oligomerization with Smad4 [71-73], 
resulting in a decrease in the nuclear export rate and the subsequent nuclear 
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accumulation of the Smad proteins [74]. Upon nuclear accumulation, the 
Smad proteins act as transcription factors, which regulate changes in the 
cellular transcriptome to elicit the  appropriate cellular response [69]. Non-
cannonical signaling is less well understood, where ligand stimulation leads to 
the activation of several MAP Kinase (MAPK) proteins, including ERK1/2, 
P38 and JNK, in a cell type specific manner [57, 75-81]. Activation of 
MAPKs has been shown in at least one case to be achieved through Ras 
activation by SHC and TRAF6, which interact directly with TβRI [80]. 
Although the non-canonical TGFβ pathway is required for ligand induced 
cellular migration [57], the mechanism by which ligand stimulation leads to 
collective and directed cellular migration remains unknown.   
 
MEK1 and Cellular Migration 
MEK1 kinase activity has been implicated in the regulation of cellular 
migration as a regulator of actin polymerization and as a potential collective 
migration guidance cue. MEK1 regulation of actin polymerization has been 
shown to occur through the Ras-MEK1 pathway’s ability to inhibit LIM 
Kinase in 3 dimensional in vitro studies [82]. LIM kinase phosphorylates and 
inactivates the actin remodeling protein cofilin, whose main function is to 
sever actin filaments at internal locations [82-85]. Cofilin mediated severing 
of actin filaments is recognized to be an important step in the generation of 
membrane protrusions, particularly in lamellipodia formation [86]. Thus, 
MEK1 kinase activity is required for the membrane protrusion step in the 
process of cellular migration.  
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Additionally, MEK1 activity has been shown to regulate the ability of 
CDC42 to activate JNK kinase [87]. Although MEK1 has been shown to 
regulate CDC42, and CDC42 has been shown to regulate cellular polarity, 
MEK1 has not been directly shown to regulate CDC42’s ability to mediate 
cellular polarity [17, 87]. As a result, the full understanding of the mechanism 
by which MEK1 regulates cellular migration requires further investigation.  
In addition to regulating actin remodeling in individual cells, MEK1 
kinase activity has been proposed to be involved in the directional guidance of 
collectively migrating cells [8, 11, 88]. Such guidance is thought to be 
achieved through the asymmetric distribution of cells with high MEK1 
activity throughout a collectively migrating group of cells. This asymmetry 
has been shown in migrating epithelial sheets and 3 dimensional spheroids 
[89-91]. In all of these cases, the direction of collective migration correlates 
with the orientation of MEK1 activity in the collective group. However, it is 
not known how such asymmetric MEK1 activity effectively guides a 
collectively migrating group of cells, nor is it known exactly how such 
asymmetry occurs [11]. In addition, no investigation has addressed whether 
spatial constraint of MEK1 activity causes different collective migration 
compared to uniform MEK1 activation. Since malignant tumors are frequently 
shown to have increased MEK1 activity, there is a clear need for future 
studies to investigate the role of MEK1 in both individual cell migration and 
collective cell migration in order to better understand the process of cancer 
metastasis. 
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CHAPTER II 
 
The Development of Novel High Throughput Computational Tools For 
Studying Individual and Collective Cellular Migration 
 
INTRODUCTION 
 
 
The Motivation for Improved Computational Tools for Measuring Cell 
Migration 
Cellular migration is an important process in cancer progression, development, 
tissue repair, and immune response [2, 5, 88, 92-95]. As a result, a plethora of 
research has been performed to identify the molecular mechanisms behind how 
individual cells achieve migration, as well as how neighboring cells migrate 
cooperatively in collective migration (reviewed in [7, 9, 14] and [11], respectively). 
Primarily, this research has been conducted through the tracking of cells in a two 
dimensional cell culture model system using time-lapse fluorescence microscopy, a 
task that has proven to be a challenge without the use of an automated cell tracking 
software.  Although such motility programs exist (Table 2.1), they differ in the 
parameters they report, largely ignore the parameters of migration direction and 
migration persistence, and lack the high throughput capability of analyzing multiple 
videos. In order to provide a tool with such capabilities to the cell migration field, we 
have developed an automated high throughput cell tracking software, named 
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Pathfinder, which is capable of measuring and reporting cellular speed, cellular 
direction and migration persistence of fluorescently labeled cells. 
 
Cellular Migration Persistence Measurements 
The migration persistence of cells (the ability of cells to migrate continually in 
one direction)  is the result of a cyclical process of front end extension and rear 
retraction, which involves the anterior to posterior polarization of actin dynamics 
throughout a cell [1, 19, 26, 96]. Such actin dynamics are governed by the 
polarization of multiple biochemical activities within a cell, including Rac and 
CDC42 GTPases at the front end [1, 17, 18, 20, 97, 98], which regulate where in a 
cell actin is polymerized, through their effector proteins WASP and WAVE [16]. At 
the sides and rear of the cell, Rho GTPases suppress the activity of Rac, which in turn 
prevents actin polymerization at these locations [21, 39]. These actin regulating 
proteins are themselves regulated by complex signaling networks that can accept 
input signals from extracellular sources, including cytokines, matrix composition, 
and physical stimuli [5, 6, 99]. Alterations in migration persistence presumably 
reflect the changing polarity of actin regulating proteins, where cells that constantly 
reestablish the relative location of actin regulating proteins migrate with poor 
persistence, and turn more frequently. However, it is not entirely clear how cells alter 
polarity during cellular migration [1]. Nevertheless, the quantitative measurement of 
the persistent behavior of cells is likely to be a required technique to understand how 
cells actively respond to their surroundings.  
Although all of the cellular motility programs that are available report the speeds 
of cells, only one published program allows for the measurement of migration 
persistence by reporting the persistence time, or the estimated time that a cell 
commits to a well defined direction (Table 2.1). We discuss the short comings of the 
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method of measuring persistence time, as well as how we use an alternative 
parameter, termed the angle of deflection, which reports the instantaneous change in 
direction of a cell. The method of calculating the angle of deflection of a cell 
overcomes the limitations of persistence time measurements and can accurately 
report when a population of cells responds to an environmental stimulus by altering 
cellular migration persistence. Thus, our improved method aims to significantly 
contribute to the cell migration field by providing a robust means for instantaneous 
observation of migration persistence throughout a large population, as well as for 
individual cells. 
 
The Need for Quantitative Methods for Measuring Collective Cell 
Migration 
In addition to investigations of individual cell migration, investigations into the 
mechanisms behind collective cell migration are becoming more abundant in the cell 
migration literature. Collective migration is defined as the ability of physically 
interacting cells to adopt a common migration direction [10, 11]. The collective 
migration of cells is an important process in cancer progression, development and 
wound repair [8, 51, 53, 54, 56, 57, 66]. Such collective behavior results largely from 
each cell responding to the environmental stimuli of neighboring cells, in addition to 
non-cell environmental stimuli [1, 10, 11]. Although collective migration is 
recognized as important for many biological processes, high throughput 
computational tools to measure collective migration have not been made readily 
available to researchers. For this reason, our Pathfinder software was developed with 
the capability to report the directions of each cell in each frame of a time-lapse 
microscopy video. This parameter, termed the angle of trajectory, allows researchers 
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to determine whether neighboring cells share a common migration direction, which is 
an accepted required feature of collective migration [3, 4, 10, 11].  
 
The Pathfinder Software’s Contribution to the Field of Cellular 
Migration  
Although technological advances in fluorescence microscopy continue to propel 
the cell migration field forward, the current limitation for researchers is not rooted in 
data acquisition, but rather in data analysis. Our newly developed high throughput 
cell migration software overcomes this limitation, as it provides the means to 
quantify turning behavior in individual cells and to quantify collective behavior in 
groups of cells, both with time resolution. As a result, this novel software is likely to 
dramatically contribute to the cell migration field’s ability to investigate not only the 
molecular mechanisms behind cellular migration, but also how cells sense and 
respond to their neighbors.   
Methods 
 
Fluorescent Labeling of Cells, Cell Culture and Cellular Imaging 
Stable transgenic HaCaT and MDA-MB-231 cell lines were fluorescently labeled 
via retroviral mediated gene transfer of mCherry-Histone H2B using the pRex-
mCherry-H2B plasmid. For all experiments, cells were cultured in DMEM lacking 
phenolphthalein red and supplemented with 2 mM L-glutamine, 100 Units/mL 
penicillin and 100 µg/mL streptomycin. For low density assays, cells were plated at 
an average density of 300 cells/mm2 for both HaCaT and MDA-MB-231 cells. For 
confluent monolayer experiments, HaCaT cells were plated at an average density of 
1000 cells/mm2. For Epithelial sheets assays, HaCaT cells were plated at an average 
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density of 1200 cells/mm2 for 3 hours at 37 °C, after which half of partially adherent 
cells were manually removed using a 200 µl pipet tip. An ImageXpress MicroXL 
high throughput wide-field fluorescence microscope was used for imaging 
experiments at 37 °C and 5 % CO2. All microscopy videos were acquired with a 
frame rate of one frame every seven minutes, in the mCherry fluorescence channel. 
The accompanying MetaXpress software was used to compile video files from time-
lapse images for each well of a 96 well plate.  
 
Programming, Input Parameters, and Output for the Pathfinder Software 
The Pathfinder software was written in the Java programming language. User 
specification is required for cell size (pixels), minimum track length, the interval of 
frames for desired calculations (Frame _ –Frame _), Percentage of pixels that 
represent cells, and the directory path for the folder containing .avi files. The output 
for each video file is a single Excel spreadsheet (Figure 2.3).  
 
Calculation of Migration Parameters, Persistence Time and Nearest Neighbor 
Analyses 
Cellular speed was calculated as the displacement of a cell (pixels) over 1 frame. 
Conversion to µm/hour is determined by the following equation:  
𝐶𝑜𝑛𝑣𝑒𝑟𝑠𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 =  (𝐶𝑎𝑚𝑒𝑟𝑎 𝑃𝑖𝑥𝑒𝑙 𝑆𝑖𝑧𝑒×𝐵𝑖𝑛𝑛𝑖𝑛𝑔 𝐹𝑎𝑐𝑡𝑜𝑟)(𝑀𝑎𝑔𝑛𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟×𝐹𝑟𝑎𝑚𝑒 𝑅𝑎𝑡𝑒)   
The Angle of Trajectory was calculated from the following discontinuous equations: 
   𝒊𝒇(𝒅𝒙 > 0,𝑑𝑦 > 0), 𝒕𝒉𝒆𝒏  𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 = 𝟑𝟔𝟎 − 𝑨𝒓𝒄𝑻𝑨𝑵�𝒅𝒚𝒅𝒙�      
  𝒊𝒇(𝒅𝒙 > 0,𝑑𝑦 < 0), 𝒕𝒉𝒆𝒏   𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚   = −𝑨𝒓𝒄𝑻𝑨𝑵�𝒅𝒚𝒅𝒙�     𝒊𝒇(𝒅𝒙 < 0,𝑑𝑦 > 0), 𝒕𝒉𝒆𝒏  𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚  = 𝟏𝟖𝟎 − 𝑨𝒓𝒄𝑻𝑨𝑵�𝒅𝒚𝒅𝒙�                                                                                    𝒊𝒇(𝒅𝒙 < 0,𝑑𝑦 < 0), 𝒕𝒉𝒆𝒏   𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 = 𝟏𝟖𝟎 − 𝑨𝒓𝒄𝑻𝑨𝑵�𝒅𝒚𝒅𝒙�            
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   𝒊𝒇(𝒅𝒙 = 𝟎,𝒅𝒚 = 𝟎), 𝒕𝒉𝒆𝒏   𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 = 𝑵𝒐 𝑨𝒏𝒈𝒍𝒆                                                              𝒊𝒇(𝒅𝒙 > 0,𝑑𝑦 = 0), 𝒕𝒉𝒆𝒏   𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 = 𝟎    𝒊𝒇(𝒅𝒙 < 0,𝑑𝑦 = 0), 𝒕𝒉𝒆𝒏   𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 = 𝟏𝟖𝟎                                                                               𝒊𝒇(𝒅𝒙 = 𝟎, 𝒅𝒚 < 0), 𝒕𝒉𝒆𝒏   𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 = 𝟗𝟎                              𝒊𝒇(𝒅𝒙 = 𝟎,𝒅𝒚 > 0), 𝒕𝒉𝒆𝒏  𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 = 𝟐𝟕𝟎 
 
Angle of Deflection was calculated from the following discontinuous equations:                                                  𝒊𝒇�𝜽𝑫𝒆𝒇𝒍𝒆𝒄𝒕𝒊𝒐𝒏 ≥ 𝟏𝟖𝟎�, 𝒕𝒉𝒆𝒏  𝜽𝑫𝒆𝒇𝒍𝒆𝒄𝒕𝒊𝒐𝒏 =  �𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 𝒕=𝒏+𝟏 − 𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 𝒕=𝒏  � − 𝟑𝟔𝟎                𝒊𝒇�𝜽𝑫𝒆𝒇𝒍𝒆𝒄𝒕𝒊𝒐𝒏 ≤ −𝟏𝟖𝟎�, 𝒕𝒉𝒆𝒏  𝜽𝑫𝒆𝒇𝒍𝒆𝒄𝒕𝒊𝒐𝒏 =  �𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 𝒕=𝒏+𝟏 − 𝜽𝑻𝒓𝒂𝒋𝒆𝒄𝒕𝒐𝒓𝒚 𝒕=𝒏  � + 𝟑𝟔𝟎   
 
Persistence measurements were performed using both the “Cell Motility Project” 
program and a modified in-house MatLab based program developed by Dr. Douglas 
Lauffenburger (MIT). Results display calculations from the latter program.  
Nearest neighbor calculations were done in Excel using an inter-centroid distance 
matrix of (all cells) x (all cells) for each frame. Nearest neighbors were defined as 
cells within whose centroids are within 100 µm of each other. 
 
Overlapping Intervals Suppresses Noise in Directional Cellular Behavior 
The Pathfinder software is unique from other software in that it calculates 
angular information about individual cells. However, such angular information 
requires that the determination of a cell’s position be relatively noise free. When we 
closely examine the tracks of individual cells, we find that tracks exhibit slight 
vibration on the short timescale (7 minutes), such that a cell that migrates relatively 
straight does not display a perfectly straight track. As a result, we use overlapping 
intervals for our calculations of angular information in order to suppress the effects of 
such vibration on angular calculations. The schematic diagram in Figure 2.1A 
illustrates how overlapping intervals aid in the reduction of noise in the calculation of 
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cellular speed, direction, and persistence. Presented is the path of a single 
hypothetical cell that travels from positions 1 to 6. When calculating the trajectory of 
the movement from position 1 to 2, the resulting vector does not accurately represent 
the underlying trajectory of the cell over time. However, as the calculation is repeated 
in the same manner for a change in position from 1 to increasing successive 
positions, the resulting vectors quickly to converge on the underlying trajectory of the 
cell. Each interval represents the cellular behavior in a video that has a frame rate that 
is the (acquisition frame rate) x (the interval size). For instance, if the interval size is 
3 frames, then calculations are conducted on frames 1,4,7,10, and so forth. When 
successive intervals are combined, with a single frame shift from one interval to the 
next, the resulting data provides a time dependent parameter that has greatly 
suppressed noise. Figure 2.1B and C show the effect of increasing interval size on the 
time dependent average absolute angle of deflection trend (B) and the average 
standard deviation of the absolute angle of deflection trend (C) for HaCaT cells 
treated with TGF. With an interval size of 1 frame, both the average (B) and the error 
(C) of the angle deflection measurements are extremely noisy. With increasing 
interval size, such noise is suppressed, where an interval size of greater than 2 does 
not yield significant additional suppression of noise. For all cellular experiments 
detailed in this investigation, an interval size of 3 frames was used. This method of 
overlapping intervals was applied to all measurements, with the exception of 
persistence time measurements. 
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Results 
 
The Overview and Capabilities of the Pathfinder Software 
The Pathfinder software was developed to allow researchers to easily analyze 
large data sets of time-lapse fluorescence microscopy videos of motile cells. Since 
cellular tracking is already a well-established technique, our software implements a 
previously validated tracking algorithm (“Particle Tracker”) developed by Sbalzarini 
et. al  to detect each fluorescently labeled nuclei in each frame (Figure 2.2A), as well 
as to assemble such positional information into cellular tracks (Figure 2.2B), as 
described in their publication [100]. Since cellular positions alone are of little use to 
researchers in the cell migration field, we developed an analysis algorithm to 
transform the previous Particle Tracker output into an excel spreadsheet that displays 
calculations of the speed, the persistence, and the direction of individual cells, as well 
as the average values for a population of cells (Figure 2.2B and Figure 2.3). In 
addition, Pathfinder is capable of running batch parallel processing of unlimited .avi 
files, allowing for automated and high throughput data processing of fluorescent 
time-lapse microscopy videos.  
  
Using the Average Absolute Angle of Deflection to Measure Cellular Persistence 
In order to provide a means for high throughput calculation of cellular migration 
persistence, we used a non-traditional, but direct, approach of calculating the angle of 
deflection for each cell at each time. Figure 2.2B illustrates how the angle of 
deflection measures migration persistence. The diagram represents a single cell, 
whose position is measured at three successive time points (1, 2, and 3, respectively). 
As the cell travels from 1 to 2 it maps out a line representing the trajectory of the cell 
between these two times. Similarly, as the cell travels from 2 to 3, another line is 
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Figure 2.2 Angular Measurements of Cellular Migration Can Reveal Cellular Behavior. A) The 
Pathfinder program converts time-lapse microscopy videos of fluorescent HaCaT cells (left) to cellular 
tracks (right). B) The Pathfinder program uses the positional information of cellular tracks to calculate 
speed (top), migration persistence through the absolute angle of deflection (bottom), and the migration 
direction relative to a well-defined axis orientation in the field of view (right). C) Cells do not prefer to 
turn right or left in either the presence (right) or absence (left) of EGF stimulation. A binned histogram of 
percent of cells versus percent of right turns is normal and centered around 50 percent. D) A comparison 
of persistence time calculations and average absolute angle of deflection methods for measuring 
migration persistence yields identical trends in both the presence and absence of either TGF-Beta or EGF 
for MDA-MB-231 cells and HaCaT cells.  
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formed. The angle of deflection is the angle between these two lines, where a 
clockwise turn has a positive value, and a counterclockwise turn has a negative value. 
Using this calculation, each cell at each time can be assigned an angle of deflection,  
such that the sampling of many cells at a single time point can provide an accurate 
measurement of how straight cells are migrating within the population. A decrease in 
the average absolute value of the angle of deflection for a population of cells 
(��𝜽𝑫𝒆𝒇𝒍𝒆𝒄𝒕𝒊𝒐𝒏��) reflects an increase in the migration persistence. We use the absolute 
value of the angle of deflection for describing the persistence of migration in large 
populations, rather than maintaining the sign of the angle of deflection, because cells 
do not display a bias in which direction they prefer to turn (Figure 2.2C).  
Although we measure migration persistence using the average absolute angle of 
deflection, the measurement of migration persistence is currently conducted in the 
cell migration field through the determination of persistence time, which is calculated 
using data fitting of time dependent mean squared displacement trends to Equation 1, 
where 𝑀𝑆𝐷 is the mean squared displacement of the cell,  𝑛𝑑  is the number of 
dimensions in which cells are migrating,  𝑆2 represents the squared speed of the cell,  
P represents the persistence time of a cell,  and t is the time. 
 
   𝑀𝑆𝐷 = 𝑛𝑑𝑆2𝑃𝑡 �1 − 𝑃𝑡 (1 − 𝑒−𝑡𝑃)�                                            Equation 1 
 
Persistence time is used to measure migration persistence because local changes 
in mean squared displacements trends are likely to be associated with changes in the 
direction of cellular migration, provided that speed is taken into consideration. A key 
difference between our approach and the persistence time approach is that persistence 
time measurements focus on how long a cell maintains a direction, while the average 
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absolute angle of deflection measurements focus on the degree to which cells in a 
population turn in each frame. Thus, persistence time measurements reflect behavior 
over a specified interval of time (usually 2-4 hours), while the average absolute angle 
of deflection measurements reflect the relatively instantaneous behavior of cells. 
 We compared our technique of measuring migration persistence to the method of 
measuring persistence time by examining the time-lapse microscopy videos of two 
cell lines, MDA-MB-231 and HaCaT, stably expressing fluorescent nuclear markers 
and treated with no ligand, TGFβ or EGF. When such videos of HaCaT cells (24-26 
hours post ligand stimulation) are analyzed by the two methods, both techniques lead 
to the same conclusions; TGFβ and EGF stimulation cause increased migration 
persistence, where EGF has an impact of higher magnitude than that of TGFβ (Figure 
2.2D, right). Both methods also agree when the same analysis is applied to MDA-
MB-231 cells, where only TGFβ has a low magnitude effect on migration persistence 
(Figure 2.2D, left). Thus, these techniques yield the same results under these 
experimental conditions. Taken together, this data shows that these two techniques 
both accurately measure migration persistence in motile cells. 
 
The Shortcomings of Measuring Persistence Time  
Although persistence time calculations are often used in motility investigations, 
they are computationally expensive due to the data fitting technique that they employ, 
require uniform track lengths, and are sensitive to the interval of time being 
examined. The largest flaw of the persistence time method is that it is sensitive to the 
interval of time being investigated. This phenomena has been described by others, 
where cells are observed to migrate with poor persistence on long time scales (>6 
hours) [101]. To illustrate this point, we repeated our persistence time and average 
absolute angle of deflection calculations over a 9 hour timescale. Although the 
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average absolute angle of deflection technique reveals an almost identical trend, the 
trend for persistence time calculations is extremely different (Figure 2.4A). In this 
case, ligand treatments are apparently causing decreasing migration persistence, and 
all persistence times have unrealistic magnitudes (>>1000 minutes). Thus, 
persistence time measurements are sensitive to the interval of time pre-determined by 
the researcher, requiring a complicated method for determining the reliable interval 
of time that yields accurate results. The dependency of persistence time calculations 
on time interval size means that comparisons between cells are only valid if track 
lengths are identical. In high throughput analysis of cellular migration, this would 
lead to truncation of data, such that all cells that are unsuccessfully tracked 
throughout a given time are discarded. This truncation is not necessary when using 
the average absolute angle of deflection method, as each angle of deflection is 
calculated for a cell on a single frame basis. The sensitivity to time interval size 
makes the persistence time method an inferior choice for time dependent analysis of 
migration persistence in time-lapse videos.  
We further analyzed the technique of persistence time measurement by plotting 
the trend of R2 values from data fitting versus the calculated persistence time. This 
trend shows a clear relationship between these two parameters, where low persistence 
times are assigned to mean squared displacement trends that are poorly fit (Figure 
2.4B). This suggests that the accuracy of persistence time calculations for poorly 
persistent cells is low. For this reason, we compared the persistence times with the 
average absolute angle of deflection values for cells from the summation of our 
experiments, discussed below, in which data fitting was successful (R2 > 0.9).  Such 
comparison reveals that the two parameters are proportional to each other (Figure 
2.4C). The relationship between these two parameters was further shown to be linear 
between the inverse of persistence time and the square of the average absolute angle 
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Figure 2.4 Extended Comparison of Migration Persistence Time Calculations and Average 
Absolute Angle of Deflection Calculations. A) Persistence time calculations report unrealistically high 
migration persistence times and misleading ligand dependent trends upon the increasing of sampling time 
to 9 hours for both MDA-MB231 and HaCaT cells (left two). Alternatively, the average absolute angle of 
deflection method is largely insensitive to increases in sampling time interval size (right two). B) In 
persistence time calculations over the duration of 2 hours, data fitting success correlates with persistence 
time magnitude. C) For cells with successful data fitting in the persistence time method (R2>0.9), 
persistence time measurements and average absolute angle of deflection measurements correlate with 
each other on a single cell basis. Averaging of absolute angle of deflection measurements was conducted 
over 2 hours, consisting of approximately 17 time points. D) The same cells were used to show that the 
square of the average absolute angle of deflection correlates directly with the inverse persistence time for 
each cell. E) Cells with poor data fitting in persistence time measurements are unlikely to report accurate 
measurements of migration persistence, as the square of the average absolute angle of deflection does not 
correlate directly with the inverse persistence time for each cell. The cells used for B,C,D, and E represent 
random sampling of cells from a combined dataset of untreated, TGF-beta, and EGF treated HaCaT cells.  
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of deflection (R2 > 0.72) (Figure 2.4D). However, the same relationship does not 
exist for cells that exhibited a poor data fitting score for persistence time calculations 
(R2 < 0.9) (Figure 2.4E). Taken together, these data show that the persistence time 
calculation is likely to be largely qualitative, and not quantitative, for cells in which 
data fitting was unsuccessful.  
In light of the three aforementioned shortcomings of persistence time 
measurements, we chose the angle of deflection method for our computational 
motility program, which produces identical results to that of persistence time 
measurements on short timescales (2 Hours), is insensitive to interval size, reports 
migration persistence nearly instantaneously, and is relatively computationally 
inexpensive.  
 
Measuring Time Dependent Changes in Migration Persistence and Speed 
Upon mere qualitative assessment of cellular tracks, cellular behavior is difficult 
to deduce for large populations of cells. For example, when we examine MDA-MB-
231 and HaCaT cell migration in response to either TGFβ or EGF by looking at the 
tracks of cells between 0 and 35 hours post ligand stimulation, MDA-MB-231 cells 
appear to not change behavior in response to ligand treatments and HaCaT cells 
appear to respond in the same manner upon TGFβ and EGF stimulation (Figure 2.5A 
and B). However, MDA-MB-231 cells do in fact respond to ligand stimulations and 
HaCaT cells do in fact respond differently to TGFβ and EGF stimulation, which is 
elaborate upon below. Thus, only through rigorous quantitation can large populations 
be characterized for their cellular behavior. 
 Using our quantitative approach to measuring cellular migration, we were able 
to determine that either TGFβ or EGF causes MDA-MB-231 cells to migrate faster, 
but has almost no effect on how persistently cell migrate. Only ligand stimulation of 
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Figure 2.5 Measuring Individual Cellular Behavior with the Speed and Migration Persistence 
Reveals Cell Type and Ligand Specific Cellular Migration Behavior. Cellular tracks of low density 
cells are displayed for treatments of either Mock, TGF-Beta or EGF for MDA-MB-231 cells (A) or 
HaCaT cells (B). Calibration bars represent 150 µm.  C) Neither TGF-Beta nor EGF stimulation affects 
migration persistence in MDA-MB-231cells (top). In contrast, both treatments affect cellular speed, but 
with different induction kinetics (bottom). D) In HaCaT cells, both ligand treatments affect migration 
persistence and cellular speed (top and bottom, respectively). However, EGF stimulates migration 
persistence with earlier kinetics than that of TGF-Beta (top), and EGF is a poor stimulator of migration 
speed (bottom, right).  
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TGFβ causes a statistically significant (p= 0.003), but extremely small change in 
magnitude,  
decrease in migration persistence, as evident by a slight elevation in the average 
absolute angle of deflection of cells (Figure 2.5C, top left). Both TGFβ and EGF 
treatments yield an increase in the average speed of these cells, where EGF response 
is early (approximately 1 hour after treatment) and TGFβ response is late 
(approximately 10 hours) (Figure 2.5C, bottom). Thus, ligand stimulations cause 
MDA-MB-231 cells to speed up, rather than migrate more persistently. 
In contrast to MDA-MB-231 cells, both speed and migration persistence are 
activated by TGFβ and EGF treatment in HaCaT cells, where the effects of EGF 
appear early (approximately 1 hour) and the effects of TGFβ appear late 
(approximately 10 hours) (Figure 2.5D). Taken together, these data illustrate the 
importance of time resolution in measuring cell migration responses to environmental 
stimuli, as well as the importance of measuring both the speed and the persistence of 
cells in order to characterize the full behavior of cell migration.  
 
Quantifying Collective Migration with Nearest Neighbor Analyses of Angular 
Measurements 
The increasing interest in the collective behavior of cells in the cell migration 
field prompted us to integrate the capability of characterizing collective migration 
into the Pathfinder software. We introduced the parameter of “the angle of trajectory” 
to provide a tool for researchers to determine if a group of cells is migrating 
collectively or independently. For this parameter, each cell is assigned an angle that 
ranges from 0 to 359 degrees relative to a well-defined set of axes in the field of 
view. Figure 2.2B (right) illustrates the orientation of these axes in the field of view, 
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and provides an example of a cell that is migrating in the direction of 45 degrees. In a 
similar manner to the case of angle of deflection, each cell gets such an assignment  
for each time, providing time resolution of cellular direction. In order to demonstrate 
how the angle of deflection calculation can be used to characterize collective 
migration, we examined HaCaT and MDA-MB-231 cells in confluent monolayers in 
response to EGF stimulation. Manual inspection of the cellular tracks of these 
monolayers suggests that neighboring cells migrate in a similar direction in a ligand 
dependent manner in HaCaT cells (Figure 2.6A, top). This behavior is not observed 
for MDA-MB-231 cells (Figure 2.6A, bottom). Since collective migration is defined 
as the ability of cells to adopt a common migration direction, we quantified the 
average standard deviation of the angle of trajectory, also referred to as the “paired 
random migration index” (PRMI ӨTrajectory), amongst pairs of nearest neighboring 
cells at 24 hours post ligand stimulation. An increase in this quantity indicates that 
nearest neighboring cells are migrating in increasingly different directions, meaning 
collective migration is decreasing. We excluded pairs of neighbors in which one cell 
migrates with a direction of 0-90 degrees and another cell migrates in a direction of 
270-360 degrees, as these pairs would have a falsely high standard deviation due to 
the discontinuous transition between 360 degrees and 1 degrees. In agreement with 
our qualitative observations of cellular tracks, nearest neighboring HaCaT cells 
display a lower PRMI ӨTrajectory  in response to EGF stimulation (Figure 2.6B, top left). 
We compared nearest neighbor behavior to random pairing behavior in order to 
identify when shared behavior of cells is global versus local. If random pairing does 
not change the magnitude of the PRMI ӨTrajectory, then the shared behavior is entirely 
global. In contrast, when such magnitudes are affected by random pairing, the 
phenomena is local. Upon random pairing of HaCaT cells, a similar trend is observed 
for the PRMI ӨTrajectory, but the magnitudes increase for both mock treatment and EGF 
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Figure 2.6 Angular Measurements Can be Used to Quantify Collective Migration Behavior. A) 
Cellular tracks of confluent monolayers of HaCaT (top) and MDA-MB-231 cells (bottom) in the presence 
and absence of EGF stimulation. Calibration bar represents 150 µm. B) Confluent monolayers of HaCaT 
cells in the presence and absence of EGF stimulation were quantified for their collective migration 
behavior by calculating the average standard deviation of either the angle of trajectory (also called the 
paired random migration index (PRMI ӨTajectory))(top, left) or the angle of deflection (PRMI ӨDeflection) (top, 
right) amongst nearest neighboring cells. Random pairing was used to determine whether the observed 
behavior was local or global amongst the population. The same quantification was conducted for MDA-
MB-231 cells (bottom). C) Cellular tracks of epithelial sheets of HaCaT cells in the presence and absence 
of EGF stimulation. Calibration bar represents 150 µm. D) Inspection of the spatial distribution of 
collective migration behavior reveals that EGF stimulation elicits collective migration uniformly 
throughout an epithelial sheet, when either the PRMI ӨTajectory (left) or the PRMI ӨDeflection (right) is used to 
calculate collective behavior.  
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treatment (Figure 2.6B, top left). Thus, HaCaT cells exhibit local collective migration 
in the absence of ligand stimulation, which becomes activated in response to EGF. 
Using the same technique on MDA-MB-231 cells, these cells display a statistically 
significant, but low magnitude, increase in the PRMI ӨTrajectory  amongst nearest 
neighbors in response to EGF, suggesting that ligand stimulation of these cells causes 
neighboring cells to exhibit slight repulsion, and migrate more in opposing directions 
upon EGF stimulation (Figure 2.6B, bottom left). Random pairing of MDA-MB-231 
cells led to an increase in the magnitude of the PRMI ӨTrajectory, revealing that the 
collective migration of these cells is a local phenomenon (Figure 2.6B, bottom left). 
Whether or not the apparent collective migration behavior of neighboring MDA-MB-
231 cells in the absence of ligand stimulation constitutes collective migration 
according to the accepted definition will require further investigation into the 
requirement of cellular junctions in this process. However, it is worth noting that the 
neighboring cells do in fact have physical contact with each other (Figure 2.7), albeit 
for short timescales (data not shown). 
Although cooperation amongst nearest neighbors in the angle of trajectory is a 
recognized necessity for collective migration, we investigated whether the 
cooperation amongst nearest neighbors in the angle of deflection is also characteristic 
of collective migration. We repeated our nearest neighbor analysis for the angle of 
deflection measurements by calculating the PRMI using the angle of deflection 
measurement (PRMI ӨDeflection), which revealed that HaCaT cells display local 
cooperation in migration persistence in the presence of EGF. Upon EGF stimulation, 
random pairing has little effect on the average standard deviation amongst nearest 
neighbors of the angle of deflection, suggesting that persistent migration is globally 
exhibited by these cells (Figure 2.6B, top right). Thus, the angle of deflection cannot 
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be used to calculate collective migration in the PRMI calculation, because cellular 
migration persistence is a common feature amongst distant cells under these 
circumstances. MDA-MB-231 cells do not exhibit changes in the magnitude of the 
PRMI ӨDeflection upon random pairing in either the presence or absence of EGF, 
suggesting that migration persistence and collective behavior are mutually exclusive 
in these cells (Figure 2.6B, bottom right).  Taken together, these data demonstrate our 
ability to quantify the collective migration behavior of cells by measuring the average 
standard deviation of the angles of trajectory (PRMI ӨTrajectory) amongst nearest 
neighbors. Such techniques open the door for future experiments to be conducted in 
which the molecular mechanisms behind exactly how nearest neighbors coordinate 
their migration behavior is further elucidated.  
 
Using Nearest Neighbor Analyses of Angular Measurements to Characterize 
Collective Migration in Epithelial Sheets  
 In order to determine the versatility of our method of collective migration 
quantification, we repeated our experiments on HaCaT cells using EGF stimulation, 
but under the condition in which cells were arranged into epithelial sheets (Figure 
2.6C). We asked whether or not ligand stimulation affects all cells equally in an 
epithelial sheet, and found that indeed the collective behavior response to ligand 
stimulation does not depend upon the distance from the leading edge of the epithelial 
sheet. Cells display a uniform collective migration response to EGF stimulation 
throughout the sheet, as we observed a uniform reduction in the PRMI ӨTajectory 
amongst nearest neighbors (Figure 2.6D, left). In agreement with our experiments on 
confluent monolayers, ligand stimulation also leads to global reduction in the PRMI 
ӨDeflection(Figure 2.6D, right). Since both confluent monolayers (Figure 2.6B, top) and 
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epithelial sheets (Figure 2.6D) of HaCaT cells respond similarly to EGF stimulation 
in terms of collective migration behavior, we conclude that the presence of a wound 
plays no role in whether or not these cells migrate collectively, a phenomena that has 
not been shown in the literature. Thus, our technique of quantitatively characterizing 
collective migration has already revealed a new feature of collective migration for the 
field. 
 
Discussion 
 
The Pathfinder Software Provides Novel Useful Tools For Studying Individual 
and Collective Cell Migration 
Our Pathfinder software is the first high throughput automated cell migration 
software to introduce the use of angular parameters for the measurement of cell 
migration behavior. Our parameter of the angle of deflection has proven useful for 
characterizing the migration persistence of cells in two dimensional fluorescence 
microscopy experiments. In addition to helping researchers characterize the 
molecular mechanisms behind migration persistence, this parameter can be used to 
identify the differential temporal responses of cells to distinct ligand stimulations, 
and can provide insight into the molecular mechanisms behind each ligand response. 
Furthermore, the available cell migration software has been entirely devoid of tools 
that can be used to readily characterize collective migration. As a result, 
investigations of collective migration have been more appropriately described as 
qualitative rather than quantitative. The Pathfinder software provides the first high 
throughput tool to quantitatively characterize collective cell migration using the 
“Paired Random Migration Index” (PRMI ӨTrajectory) amongst nearest neighbors with 
near single frame resolution. This tool is likely to propel the collective migration 
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field forward, as it can provide a means for accurately measuring the degree to which 
cells are migrating collectively. In conclusion, our Pathfinder software provides 
novel techniques for characterizing cellular migration in a high throughput platform, 
which are likely to aid the cell migration field in its investigation of the molecular 
mechanisms behind individual and collective migration.  
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CHAPTER III 
 
Transforming Growth Factor-Beta Induced Collective Cell Migration 
Through MEK1 Mediated Suppression of Cellular Turning 
 
INTRODUCTION 
 
Cellular motility is an important process that mediates embryonic 
development, organogenesis, immune response, metastasis, wound healing 
and tissue maintenance  [2, 3, 14, 66, 92, 93, 95]. The migration of individual 
cells in response to chemotactic signals has been extensively studied in 
mammalian and Dictyostelium model systems and is driven by a dynamic, 
polarized and coordinated process of actin polymerization and 
depolymerization, in concert with focal adhesion assembly/disassembly and 
actinomyosin contractions [7, 9, 19, 22, 26, 102, 103]. However, many 
processes in development and cancer progression depend not only on the 
motility of individual cells, but also on the collective guidance of groups of 
cells [11, 51, 53-57]. During cancer metastasis, the invasive behavior of 
tumors frequently relies on the collective migration of globular groups, 
strands, or sheets of cells [3, 47]. In all of these cases, groups of physically 
linked cells migrate coordinately in the same direction, where individual cell 
migration contributes to the directed translocation of the group. Strong 
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evidence has been presented that, in most cases, collective migration is guided 
by leader cells at the front edge of the group, which display elevated actin 
dynamics in response to external signals from the extracellular matrix or from 
the secretion of cytokines [11, 104-108].  Alternatively, collective migration 
can be driven by the pushing of cells in the rear, as has been proposed for the 
process of branching in the mammary gland [109]. However, it is not clear 
how a group of actively migrating cells, or all leader cells, achieves collective 
migration. 
MEK1 kinase activity has been implicated in the regulation of cellular 
migration as a regulator of both actin polymerization. Primarily, this has been 
shown to occur through the Ras-MEK1 pathway’s ability to inhibit LIM 
Kinase in 3 dimensional in vitro studies [82]. LIM kinase phosphorylates and 
inactivates the actin remodeling protein cofilin, whose main function is to 
sever actin filaments at internal locations [82-85]. Cofilin mediated severing 
of actin filaments is recognized to be an important step in the generation of 
membrane protrusions, particularly in lamellipodia formation [86]. Thus, 
MEK1 kinase activity is required for the membrane protrusion step in the 
process of cellular migration. Additionally, MEK1 activity has been shown to 
regulate the ability of CDC42 to activate JNK kinase [87]. Although MEK1 
has been shown to regulate CDC42, and CDC42 has been shown to regulate 
cellular polarity, MEK1 has not been directly shown to regulate CDC42’s 
ability to regulate cellular polarity [17, 87]. As a result, the full understanding 
of the mechanism by which MEK1 regulates cellular migration requires 
further investigation.  
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In addition to regulating actin remodeling in individual cells, MEK1 
kinase activity has been proposed to be involved in the directional guidance of 
collectively migrating cells [8, 11, 88]. Such guidance is thought to be 
achieved through the asymmetric distribution of cells with high MEK1 
activity throughout a collectively migrating group of cells. This asymmetry 
has been shown in migrating epithelial sheets and 3 dimensional spheroids[89-
91]. In all of these cases, the direction of collective migration correlates with 
the orientation of MEK1 activity in the collective group. However, it is not 
known how such asymmetric MEK1 activity effectively guides a collectively 
migrating group of cells, nor is it known exactly how such asymmetry occurs 
[11]. In addition, no investigation has addressed whether spatial constraint of 
MEK1 activity causes different collective migration compared to uniform 
MEK1 activation. Since malignant tumors frequently have increased MEK1 
activity, there is a clear need for future studies to further investigate the role of 
MEK1 in both individual cell migration and collective cell migration. 
In this study, we show that MEK1 activation by TGFβ stimulation is an 
indirect result of ligand induced cellular spreading, which is likely driven by 
ligand dependent weakening of cellular junctions. Such spreading is inhibited 
by high cellular density, and asymmetric cellular density in epithelial sheets 
leads to confinement of both spreading and MEK1 activity to the leading edge 
of ligand stimulated sheets. Additionally, we show that MEK1 activation in a 
group of physically interacting cells is sufficient to induce collective 
migration. Thus, the spatial constraint of MEK1 activity to the leading edge of 
epithelial sheets limits ligand dependent collective migration behavior to the 
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leading edge of an epithelial sheet. At the level of individual cells, MEK1 
activation suppresses cellular turning, suggesting that increased migration 
persistence in individual cells may be essential for collective migration to 
occur. Our study provides novel insight into the mechanism of collective 
migration, as it shows that cellular spreading, migration persistence, and 
collective migration are cellular behaviors that are linked through the kinase 
activity of MEK1. 
 
Methods 
 
Cell Culture and Experimental Platforms 
HaCaT cells were cultured in DMEM supplemented with 2 mM L-
glutamine and 100 Units/mL penicillin and 100 µg/mL streptomycin under 
5% CO2 at 37 ⁰C. For sheet migration studies, 48,000 cells (1500 cells/mm2) 
were seeded using 100 µl of media into each well of a 96 well plate. After 3 
hours half of the cells (on one side of the well) were removed using a 200 µl 
pipette tip. Non-adherent cells were removed and media was exchanged for 
100 µl of supplemented DMEM lacking phenol red. For the colony assay 
format, 7,000 cells were added using 90 µl of media to each well 24 hours 
prior to the addition of 10µl of fresh media supplemented with or without the 
appropriate ligand/inhibitor to reach the target concentration desired. In the 
cell density experiments, cells were seeded 24 hours prior to treatment such 
that the following number of cells per well were present after 24 hours of 
settling: 9,600 (300 cells/mm2), 14,400 (450 cells/mm2), 19, 200 (600 
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cells/mm2), 28,800 (900 cells/mm2), and 38,400 (1200 cells/mm2). Cellular 
densities of 300, 450, and 600 cells/mm2 result in cell colonies, while cellular 
densities of 900 and 1200 cells/mm2 results in confluent monolayers. 1 mg/ml 
Doxycycline was used to activate constitutively active MEK1 in Tet-CA cells. 
In hybrid sheet migration assays, 48,000 cells were seeded into each well. 
After 3 hours, half of HaCaT H2B GFP cells were removed, similar to the 
procedure for sheets. 48,000 HaCaT H2B mCherry cells were added to each 
well. After 3 hours, all cells were trypsinized for 2 minutes at 20 ⁰C, and a 
200 µl pipet tip was used to remove desired cells. Figure 3.1 illustrates this 
process. Images displaying the mCherry channel for hybrid sheets are the 
result of the subtraction of the mKO channel from the raw mCherry channel, 
using ImageJ, as mKO is the reporter for viral infection of Tet-control and 
Tet-CA constructs. 
 
Construction of Stable Cell lines 
Transgenic N-terminally tagged H2B mCherry cell lines were generated 
using murine leukemia virus mediate gene transfer, where 293T cells were 
simultaneously transfected with MuLV packaging vector, pHCMV-VSV-g, 
and pRex-H2B-mCherry. Viral supernatant was used to infect HaCaT cells, 
supplemented with 10 µg/ml polybrene. HaCaT H2B GFP Cells were made in 
an identical procedure with the pRex-H2B-GFP plasmid. HaCaT Tet-Control 
and Tet-CA H2B GFP cells were similarly generated using lentiviral mediated 
gene transfer, where 293T cells were simultaneously transfected with pMDLg, 
pHCMV-VSV-g, pREV and  CSIV-TRE-RfA-CMV-KT, or  CSIV-TRE-CA- 
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MEK1-RfA-CMV-KT plasmids (gifts of Hiroyuki Miyoshi, RIKEN 
BioResource Center, Japan). Constitutive active MKK1 is the R4F mutation (a 
gift of Dr. Natalie Ahn, University of Colorado), and was cloned into CSIV-
TRE-RfA-CMV-KT using gateway cloning (Invitrogen).  
 
Live Cell Imaging 
Data acquisition of mCherry timelapse videos was performed using either 
a Cellomics ArrayscanVTI fitted with a live cell chamber and Cellomics 
ArrayScan HCS Software (Thermo) or an ImageXpress MicroXL and 
MetaXpress Software (Molecular Devices). Time-lapse Imaging was done at 7 
minute intervals for 35 Hours.   
 
Cellular Tracking and Data Analysis 
Cellular Tracking and Data Analysis were performed using the Pathfinder 
software, described in Chapter II. Quantification of cellular density and 
average standard deviations in cellular density was performed using 
densitometry in ImageJ and Microscoft Excel for calculations [110]. Single 
cell evaluation of total fluorescence intensity and cellular footprint size was 
performed using the MetaXpress software.  
 
Statistical Analysis 
The error bars in all experiments represent the standard error of the mean 
(SEM), where the number of observations is 3, representing experiments done 
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in triplicate. P values for all plots were generated from a two tailed t-test 
analysis using data from three replicate trials.  
 
Western blotting 
The following antibodies and dilutions (v/v) were used 1:250 pSmad2 
(Cell Signaling #3108), 1:10000 Smad2/3 (Santa Cruz Biotechnology SC-
133098), 1:5000 Ezrin (Sigma E8897), 1:3000 ppERK1/2 (Sigma M9692), 
1:3000 ERK2 (Santa Cruz Biotechnology SC-154), 1:1000 pMEK (Cell 
Signaling 9154), 1:1000 MEK (Cell Signaling), 1:3000 Lamin A/C (SC- 
376248).  
 
Immunofluorescence 
Cells grown in 96 well plates were fixed with -20 ⁰C 100 % MeOH and 
Incubated at 4 ⁰C overnight (Endogenous) or 3.7 % PFA for 5 
minutes(fluorescent protein containing samples).  Fixed cells were rehydrated 
in Phosphate Buffered Saline (PBS) and blocked with 0.5 % BSA in 50 mM 
Tris-HCl supplemented with 0.05 % Tween-20 for 1 hour. Primary antibody 
was substituted for BSA at a dilution of 1:200 for 3 hours at room 
temperature. Secondary antibodies were used at a dilution of 1:200 for 1 hour 
at room temperature.  The antibodies used were Smad3 (SC-8332), ppERK1/2 
(Sigma M7802), Alexa555 Goat anti-Rabbit (Molecular Probes), and 
Alexa488 Goat anti-Mouse (Molecular Probes).  
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Results 
 
TGF-β Promotes Collective Cell Migration in Epithelial Sheets 
Collective cell migration and TGF-β signaling have been independently 
shown to be important processes for tissue invasion during cancer metastasis, 
prompting us to investigate whether these two processes are related to each 
other.  We developed a live cell experimental platform that allows for the 
accurate real time tracking of individual cells via the introduction of a 
fluorescent nuclear marker into the spontaneously immortalized HaCaT 
human keratinocyte cell line (HaCaT H2B mCherry Cells) (Discussed in 
Chapter 2). Since HaCaT cells display tight junctions (Figure 3.2A) and 
epithelial sheets of HaCaT cells display increased forward migration into a 
wound area upon TGF-β stimulation (Figure 3.2B and C, and Figure 3.3A), 
we investigated whether such ligand induced sheet migration constitutes 
collective migration.  We characterized collective migration behavior by 
measuring whether cells within epithelial sheets display a uniform migration 
direction, and by measuring the PRMIӨTrajectory amongst pairs of nearest 
neighboring cells (as discussed in Chapter 2). Using these two parameters, we 
found that these epithelial sheets display collective migration in the absence of 
ligand stimulation, and that this collective migration is enhanced upon ligand 
stimulation.  The migration directions that are sampled by the population are 
diverse in the absence of TGF-β (Figure 3.3B, top), and ligand stimulation 
causes such sampling to have a narrow distribution centered around 270 
52
53
54
  
 
 
 
 
 
 
 
 
Figure 3.3 Epithelial Sheets of Hacat Cells Migrate Collectively Upon TGF-Beta Stimulation. A) 
Cellular Tracks of HaCaT H2B mCherry cells reveal straight, parallel paths of cells upon TGF-Beta 
stimulation. B) Cells within 1400 µm of the leading edge of sheets display increased uniformity in the 
migration directions that are sampled upon ligand stimulation. C) The PRMI ӨTajectory was used to measure 
collective migration behavior between nearest neighbors and random neighbors. Random directions were 
substituted for angles of trajectory in nearest neighbor calculations to measure the maximum value of 
PRMI ӨTajectory , which is attributed to completely random migration behavior.  
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degrees, which is in the direction of the wound (Figure 3.3B, bottom). In 
addition, the average standard deviation of the angle of trajectory (PRMI 
ӨTrajectory)of nearest neighboring cells is lower compared to that of random 
pairing, suggesting that local collective migration is occurring even in the 
absence of ligand (Figure 3.3C). Upon TGF-β stimulation, the PRMI ӨTrajectory 
amongst nearest neighbors decreases relative to that of untreated cells, 
suggesting that ligand stimulation activates collective migration behavior 
(Figure 3.3C). Upon random pairing, the magnitude of this quantity rises, 
which means that the collective migration behavior of cells occurs stronger at 
the local level than the global level. As a control, we introduced random 
theoretical values for the angle of trajectory into both datasets, which yielded 
the same magnitude of approximately 85 degrees for the PRMI ӨTrajectory for both 
untreated cells and TGF-β treated cells, which represents the maximum value 
attributed to randomly migrating pairs of cells (Figure 3.3C). Taken together, 
this data informs us that collective migration is enhanced in epithelial sheets 
of HaCaT cells upon ligand stimulation. 
 
Epithelial Sheets Display Asymmetric Non-canonical TGF-β Signaling 
Previous studies on sheet migration have shown that epithelial sheets 
display wound-induced activation of ERK1/2 [89, 90]. Since MEK1 is both 
the kinase that phosphorylates Erk1/2 and known to be activated by the non-
canonical TGF-β pathway, we investigated whether TGF-β treatment results 
in the activation of MEK1 activity in migrating sheets of HaCaT cells.  Using 
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immunofluorescence to determine the ppErk levels at single cell resolution, 
we found that epithelial sheets display elevated ppErk levels at the leading 
edge in response to ligand stimulation (Figure 3.4A).  When the same 
epithelial sheets are examined for Smad3 subcellular localization, TGF-β 
stimulation leads to the enrichment of nuclear Smad3 uniformly across the 
epithelial sheet (Figure 3.4B), suggesting that the cells distal from the leading 
edge have active TGF-β receptor signaling, but do not respond to ligand 
stimulation in terms of MEK1 activation.  
 
MEK1 Signaling is Required for Ligand Induced Collective Migration 
Using the MEK1 inhibitor CI-1040, we found that MEK1 activity is 
required for TGF-β dependent collective migration in epithelial sheets. Upon 
exposure of sheets to a CI-1040, the ligand induced spatial constraint of 
MEK1 activity disappears (Figure 3.5A). MEK1 inhibition also increases the 
diversity of angles of trajectory throughout the population and increases the 
PRMI ӨTrajectory amongst nearest neighbors (Figure 3.5B), both of which indicate 
that MEK1 inhibition is sufficient to prevent ligand dependent activation of 
collective migration.  
 
Asymmetric MEK1 Activity and Uniform MEK1 Activity Both are 
Sufficient to Induce Collective Migration in the Absence of TGF-β 
Stimulation. 
Although asymmetric MEK1 signaling has been shown to occur in both 
two dimensional sheets of cells and three dimensional cellular spheroids, the 
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Figure 3.4 Epithelial Sheets Display Asymmetric Non-Canonical TGF-Beta Signaling. A) Phospho-
Erk1/2 staining by immunofluorescence in the presence and absence of ligand stimulation reveals that 
MEK1 activity is localized to the leading edge of epithelial sheets at 24 hours post ligand treatment. B) 
The same procedure reveals that Smad3 nuclear localization is ligand dependent, but spatially uniform.  
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Figure 3.5 MEK1 Activity is Required for Collective Migration in Epithelial Sheets. Chemical 
inhibition of MEK1 by CI-1040 inhibits MEK1 activation in epithelial sheets (A), and ligand induced 
collective migration behavior (B).  
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Figure 3.6 Hybrid Epithelial Sheets Allow for Spatial Control of MEK1 Activation. Hybrid epithelial 
sheets of WT and Tet-CA cells were constructed to limit DOX dependent MEK1 activation to the leading 
edge (A), an internal region (B), or uniformly throughout (C) epithelial sheets. 
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Figure 3.7 Characterization of Hybrid Sheet Collective Migration Behavior. Localization of MEK1 
activity in the absence of ligand stimulation can activate collective migration behavior (A). Movement of 
MEK1 activity to an internal location is not sufficient to elicit collective migration towards the wound 
area (B). Uniform Activation of MEK1 activity in epithelial sheets is sufficient to elicit collective 
migration (C). Dotted boxes indicate the region that was used to measure collective migration behavior.  
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requirement for such asymmetry in cellular migration has not been directly 
investigated [89-91]. To address the how important asymmetry is for the 
collective behavior of epithelial sheets, we constructed hybrid sheets using 
HaCaT H2B mCherry cells (WT) and HaCaT H2B GFP cells with a 
tetracycline inducible promoter driven constitutively active MEK1 kinase 
(Tet-CA), such that we could accurately control where in the collective group 
of cells MEK1 activity was stimulated. By placing Tet-CA cells at the leading 
edge of an epithelial sheet, we were able to stimulate MEK1 activity only at 
the leading edge in a doxycycline (DOX) dependent manner (Figure 3.6A). 
Similarly, Tet-CA cells could be move to an internal location, which allowed 
for DOX dependent control of MEK1 activity at an internal region of the sheet 
(Figure 3.6B). Lastly, we were able to uniformly activate MEK1 activity 
throughout a sheet in a DOX dependent manner by constructing sheets 
entirely made of Tet-CA cells (Figure 3.6C). We used these sheets to answer 
whether MEK1 activity must be at the leading edge and whether MEK1 
activity must be restricted to the leading edge. When Tet-CA cells were 
restricted to the leading edge, DOX treatment yields near identical collective 
migration behavior, as compared to TGF-β treated WT cells (Figure 3.7A and 
Figure 3.3B and C). Thus, activation of MEK1 activity at the leading edge is 
sufficient to drive collective migration throughout the epithelial sheet. 
Surprisingly, movement of Tet-CA cells to an internal location completely 
abolishes DOX dependent collective migration between the leading edge and 
the band of Tet-CA cells, suggesting that MEK1 activation at an internal 
location cannot push forward the cells in front of them (Figure 3.7B). Lastly, 
66
when sheets entirely composed of Tet-CA cells are stimulated with DOX, we 
see a similar collective migration behavior as compared to both TGF-β 
stimulated WT cells and hybrid sheets with Tet-CA cells at the leading edge 
(Figure 3.7C). Thus, Mek1 activation must be localized to the leading edge of 
an epithelial sheet in order for collective migration to occur, but need not be 
restricted only to this location.  
 
MEK1 Activity is Sufficient to Induce Collective Migration in the 
Absence of a Wound 
Since collective migration has been primarily quantitatively investigated 
using in vitro wound healing assays [63], we asked whether MEK1 induced 
collective migration required the presence of a wound, and found that it does 
not. We repeated our hybrid sheet experiment with Tet-CA cells in an internal 
band, but did not introduce the presence of a wound. This hybrid monolayer 
of cells exhibits collective migration behavior upon DOX stimulation, where a 
portion of Tet-CA cells migrate collectively upwards, and a portion of Tet-CA 
cells migrate collectively downwards, such that the hybrid sheet becomes 
increasingly dense at a central location in the band of Tet-CA cells (Figure 
3.8A). Although this behavior is complex, MEK1 activation in this scenario 
does lead to collective migration in the absence of a wound. To support this 
claim, we repeated the experiment with monolayers entirely composed of Tet-
CA cells. These monolayers also display collective migration behavior in the 
absence of a wound (Figure 3.8B). Thus, induction of collective migration in a 
group of physically interacting cells seems to be a function of whether or not 
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Figure 3.8 MEK1 Activation in Epithelial Monolayers Elicits Collective Migration Behavior. A) 
Hybrid epithelial monolayers exhibit collective migration behavior upon DOX stimulation. The outer 
dotted box indicates the region used to construct the cellular direction histogram, while the inner dotted 
box indicates the region used to measure collective migration behavior. B) In monolayers that are entirely 
composed of Tet-CA cells, DOX stimulation also yields collective migration.  
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MEK1 activity is high, and need not be limited to conditions in which a 
wound is present.  
 
MEK1 activity and Collective Migration Behavior Propagate Backwards 
in a Migrating Epithelial Sheet 
Upon closer inspection of HaCaT epithelial sheets, we found that between 
15 hours and 35 hours post TGF-β stimulation, MEK1 activity is observed 
increasingly farther away from the leading edge (Figure 3.9). As our previous 
experiments showed that the location of collective migration is a function of 
the location of high MEK1 activity throughout a collective group of cells, we 
investigated whether the collective migration behavior of cells also propagates 
towards the rear of an epithelial sheet over time. Indeed, collective migration 
behavior does propagate towards the rear, shown through a propagating time 
dependent decrease in the PRMI ӨTrajectory amongst nearest neighboring cells 
(Figure 3.10). these data in conjunction with our MEK inhibitor and hybrid 
sheet/monolayer experiments provide strong evidence that TGF-β induced 
collective migration behavior is likely to be entirely through ligand dependent 
MEK1 activation.  
 
Low Cellular Density Promotes MEK1 Activity 
Although the spatial constraint of MEK1 activity throughout an epithelial 
sheet was shown to serve only to limit the size of a collectively migrating 
group of cells, we investigated how such spatial constraint arises in order to 
better understand how MEK1 is activated by TGF-β stimulation. We found 
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Figure 3.9 Ligand Dependent MEK1 Activation in Epithelial Sheets Propagates Backwards as 
Migration Proceeds.  Epithelial sheets with and without ligand stimulation were fixed at 15, 24 and 35 
hours, and assayed for their MEK1 activity levels by immunofluorescence of ppErk1/2. Between 15 and 
35 hours, ligand treated sheets display MEK1 activation that propagates towards the rear of the sheet 
(bottom). The relative intensity of epithelial sheets was normalized to the intensity at the rear (1800 µm 
from the leading edge) of the sheet. 
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that while MEK1 activity propagates towards the rear of a migrating epithelial 
sheet, low cellular density also propagates towards the rear in a time and 
ligand dependent manner (Figure 3.11). This suggests that cellular density 
may play some role in the activation of MEK1. To test this hypothesis, we 
plated HaCaT cells at increasing cellular density and measured the ppErk1/2 
levels and found that these two parameters correlate indirectly (Figure 3.12A). 
Additionally, we measured the average cellular footprint area for these cells, 
which correlates indirectly with both cellular density and ppErk1/2 levels 
(Figure 3.12A and B). Thus, cells that are more heavily spread in either the 
presence or absence of ligand stimulation have increased MEK1 activity. 
Additionally, MEK1 activation in the absence of ligand stimulation is not 
sufficient to induce cellular spreading (Figure 3.13). Since TGF-β stimulation 
activates simultaneous cellular spreading and MEK1 activity (Figure 3.12A), 
and MEK1 is insufficient to induce cellular spreading (Figure 3.13), we 
propose that ligand dependent MEK1 activation is an indirect result of ligand 
induced cellular spreading.  
 
Cellular Spreading is Likely to Result From TGF-β Dependent 
Weakening of Cellular Junctions 
In order to better understand how TGF-β stimulation leads to cellular 
spreading and subsequent MEK1 activation, we investigated the role of ligand 
stimulation in cellular junction regulation by examining the spatial 
distribution of E-Cadherin using immunofluorescence. TGF-β stimulation 
results in structural alterations of cellular junctions, such that cellular 
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Figure 3.11 Low Cellular Density Propagates Towards The Rear of Epithelial Sheets as Migration 
Proceeds. Ligand stimulation of epithelial sheets results in decreased cellular density at the leading edge, 
which extends towards the rear of the sheet, over time. The relative intensity of epithelial sheets was 
normalized to the intensity at the rear (1800 µm from the leading edge) of the sheet. 
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Figure 3.12 Cellular Density Negatively Regulates Cellular Area and Cellular MEK1 Activity. A) 
HaCaT cells were plated at increasing cellular density, and assayed for cellular footprint area, ppErk1/2, 
pMek1, and pSmad2 levels in both the presence and absence of ligand stimulation. B) Cellular density 
and cellular footprint area correlate indirectly in both the presence and absence of ligand stimulation. 
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junctions appear to consist of highly irregular spike like projections, compared 
to the smooth perimeter structure observed in untreated cells (Figure 3.14). 
Although a significant number of experiments are necessary to determine 
whether and how alterations in cellular junctions mediate cellular spreading, 
alterations in cellular junctions may be the primary cause for ligand induced 
cellular spreading, and therefore MEK1 activation. Alternatively, cellular 
spreading could drive changes in cellular junctions, and future experiments 
are needed to determine the relationship between these two processes. 
 
Cellular Spreading is Not Required For Collective Migration 
In addition to discovering that cellular density can negatively regulate both 
cellular spreading and MEK1 activity, we also discovered that MEK1 activity 
plays an important role in density homeostasis throughout a group of 
collectively migrating cells. Upon closer examination of epithelial sheets of  
DOX treated Tet-CA cells, we found that universal MEK1 activation results in 
heterogeneous cellular density throughout a sheet, independent of ligand 
stimulation (Figure 3.15). Not only do Tet-CA sheets not spread during their 
collective migration, but also they exhibit extremely high cell density in local 
areas that are migrating collectively (Figures 3.13, 3.15 and 3.7C). Although 
the mechanism behind how exogenous MEK1 activation leads to poor density 
homeostasis is entirely not understood, this phenomena illustrates one very 
important point: collective migration is not the mere result of cellular 
spreading within a partially confined boundary. In other words, cells do not 
need to spread in order for collective migration to occur. 
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Figure 3.15 MEK1 Activity is Required for Maintenance of Cellular Density in Epithelial Sheets. 
Epithelial sheets of Tet-CA cells were stimulated with TGF-Beta, DOX or Both treatments, and assayed 
for the variance in cellular density as a function of distance from the leading edge at 24 hours post 
stimulation. 
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TGF-β and MEK1 Suppress Cellular Turning Independent of Collective 
Migration 
Exactly how MEK1 activation leads to collective migration is not 
currently known in the collective migration field. As a result, we investigated 
the effect of elevated MEK1 activity on individual cell migration in a scenario 
in which cells are physically connected, but collective migration does not 
occur. When HaCaT cells are plated into low density cell colonies, TGF-β 
stimulation results in poorer collective cell migration, but increased individual 
cell speed (Figure 3.16A and B). Thus, this scenario is a condition in which 
ligand activation causes stimulation of individual cell migration. Using this 
experimental setup, we found that TGF-β stimulation causes suppression of 
cellular migration persistence that follows identical kinetics to that of MEK1 
activation (Figure 3.16C). This ligand effect on migration persistence occurs 
through MEK1 activation, as this effect can be blocked in a dose dependent 
manner using chemical inhibition of MEK1 activity (Figure 3.17A) and can be 
activated by exogenous expression of a constitutively active MEK1 (Figure 
3.17B). Thus, TGF-β causes suppression of cellular turning through MEK1 
activation.  
Since increasing cellular density caused inhibition of MEK1 activity, we 
tested whether increasing cellular density was able to block the ligand 
dependent activation of cellular migration persistence. Indeed, cells at a higher 
density exhibit suppressed cellular turning, independent of ligand stimulation 
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Figure 3.16 HaCaT Cells in Low Density Colonies Display Ligand Dependent Activation of 
Migration Persistence but not Collective Migration. A) HaCaT cell colonies exhibit motility upon 
ligand stimulation, where cells within colonies expand away from each other. B) Such colonies display 
decrease collective migration behavior upon ligand stimulation, but increased individual cellular speed 
(C). D) TGF-Beta stimulation of HaCaT cell colonies results in suppression of cellular turning with 
similar kinetics to MEK1 activation.  
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Figure 3.17 MEK1 Activation is Sufficient and Required for Suppression of Cellular Turning. A) 
HaCaT cell colonies were treated with increasing concentration of the MEK1 inhibitor CI-1040, which 
results in inhibition of MEK1 activity and ligand dependent suppression of cellular turning, in a dose 
dependent manner. B) Tet-CA cells in low density colonies display DOX dependent suppression of 
cellular turning that correlates with MEK1 activation.  
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(Figure 3.18A). Similarly, epithelial sheets, which display asymmetric cellular 
density (Figure 3.11) exhibit cellular migration persistence measurements that 
correlate indirectly with cellular density (Figure 3.18B). We further 
determined that exogenous expression of a constitutively active MEK1 at high 
cellular density is sufficient to overcome the effect of high cell density on 
cellular migration persistence, as these cells exhibit insensitivity to cellular 
density, and migrate with high persistence (Figure 3.19A and B). Taken 
together, this data suggests that the primary role of MEK1 in ligand dependent 
activation of cellular migration is to inhibit cellular turning, resulting in 
increased migration persistence. 
 
Discussion 
 
Cancer metastasis has been shown to occur through the invasive migration 
of either single cells or collective groups of cells into healthy tissues [3, 10, 
47]. Although TGF-β has been implicated in the metastasis of individual cells, 
the role of TGF-β in the collective migration during this process is poorly 
understood [68].  We show that TGF-β stimulation elicits collective migration 
in epithelial sheets of HaCaT cells through MEK1 activation. MEK1 
activation in these cells is likely to be the indirect result of ligand dependent 
cellular spreading. We are currently investigating the mechanism by which 
cellular spreading regulates MEK1 activity. At the level of individual cells, 
TGF-β stimulation promotes increased cellular migration persistence through 
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Figure 3.18 Cellular Density Correlates Directly with Cellular Turning Behavior. A) HaCaT cells 
were plated at increasing cellular densities and assayed for their turning behavior. B) Epithelial sheets 
display ligand dependent asymmetry in cellular turning behavior at 24 hours post ligand stimulation, 
where cells towards the leading edge turn less than those at the anterior of the sheet.  
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MEK1 activation, which may serve as a fundamental driving force for 
spontaneous collective migration.   
 
TGF-β Activation of MEK1 Through Ligand Dependent Modulation of 
Cellular Density 
 The activation of MAP Kinase proteins in the non-canonical TGF-β 
pathway is largely cell type specific [81]. Here, we show that TGF-β induced 
MEK1 activation is an indirect effect of ligand stimulation. TGF-β treatment 
causes induction of cellular spreading, which correlates strongly with MEK1 
activity (Figure 3.12A and B). Although ligand stimulation causes cellular 
spreading (Figure 3.11 and 3.12), MEK1 activation in the absence of TGF-β 
does not (Figure 3.13). Thus, we conclude that MEK1 activation likely occurs 
downstream of cellular spreading, albeit future experiments are needed to 
show whether cellular spreading alone is sufficient to drive activation of 
MEK1. Such indirect effects of TGF-β are likely to explain why non-
canonical TGF-β pathway activation is largely cell type specific, and why 
MEK1 activation is delayed (>10 hours) in HaCaT cells (Figure 3.16C).  
We propose that MEK1 activity is a central component in the mechanism 
by which individual cells sense the surrounding cellular density. As cellular 
density increases in a population of cells, cellular spreading and MEK1 
decreases (Figure 3.12B). This density sensing role of MEK1 explains why 
epithelial sheets display asymmetric MEK1 activity upon TGF-β stimulation 
(Figure 3.4A, 3.5A and 3.9), as these sheets display asymmetric cellular 
density (Figure 3.11). However, we do not currently understand the 
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biochemical mechanism by which MEK1 activity is modulated by cellular 
density. As a result we are pursuing experiments in which we perturb cellular 
junction integrity through TGF-β treatment, RNAi depletion of Alpha-Catenin 
(a known regulator of cellular junction integrity [63]) and exogenous 
expression of K- and H-Ras, while at the same time monitoring either Ras 
subcellular localization or MEK1 activity in live cells. As Ras is known to be 
a regulator of cellular junctions and to regulate MEK1 activity (reviewed in 
Chapter 4 and [81]), it serves as an ideal candidate for further investigation 
into our observed density sensing mechanism. We hypothesize that TGF-β 
stimulation ultimately leads to Ras-mediated MEK1 activation, which can be 
blocked by the additional activation of cellular junction integrity at high cell 
density. Although the mechanism of MEK1 regulation by cellular density 
requires further investigation, our observation that cellular density is a 
regulator of MEK1 activity is a novel contribution to the cell motility field 
that can explain the historic finding that cells inhibit migration in response to 
high cell density [43, 44, 46]. 
 
Spatial Constraint of MEK1 Activity is Not a Guidance Cue for 
Collective Migration 
 Although MEK1 activity has been proposed to be important for the 
guidance of collectively migrating cells, the mechanism by which such 
guidance occurs is thought to rely on asymmetric MEK1 activity throughout a 
group of cells [8, 10, 11, 111]. We show that such asymmetric MEK1 activity 
throughout an epithelial sheet does form in response to TGF-β stimulation 
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(Figure 3.4A, 3.5A and 9), but this asymmetry does not greatly impact the 
guidance of epithelial sheets, as sheets with spatially constrained and uniform 
MEK1 activity both migrate equally well towards the wound area (Figure 6A 
and C, and Figure 7A and C). In similar monolayers with uniform MEK1 
activation, collective migration appears guided in that cells collectively 
migrate in a well-defined direction, but no spatial constraint of MEK1 exists 
throughout the group (Figure 3.8B). We propose that the low resistance of 
paths that lead into the wound serve as the dominant guidance cue for 
collective migration, in agreement with other investigations [3, 11].  This 
principle can also explain our peculiar observation that epithelial monolayers 
with spatially constrained MEK1 activity seem to exhibit collective migration 
towards MEK1 activity, in the absence of the wound (Figure 3.8A). In this 
case, we propose that the path of least resistance for a cell with high MEK1 
activity is to migrate towards another migrating cell, and away from a non-
motile cell. In this manner, cells with high MEK1 activity always orient their 
migration away from non-motile cells, creating the appearance that collective 
migration is guided by spatial constraint of MEK1 activity. Based on our 
experiments, MEK1 seems to directly control whether or not collective 
migration occurs, rather than in what direction it travels (discussed below). 
Therefore, guidance of individual cells in a collectively migrating group is 
likely to be determined primarily by where physical resistance is encountered, 
such that cells migrate away from resistance.  
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MEK1 Activation Suppresses Cellular Turning 
Our data suggest that one role of MEK1 in collective migration is to 
suppress cellular turning. We found that ligand activation of MEK1 and 
exogenous activation of MEK1 are sufficient to cause increased migration 
persistence, which is causally linked to suppression of cellular turning (Figure 
3.16C and 3.17B). Inhibition of MEK1 activity through chemical inhibitors or 
the indirect effects of cellular density was sufficient to inhibit migration 
persistence and activate cellular turning (Figure 3.17A, 3.18 and 3.19). 
Clearly, the ability of an individual cell to travel in a straight path is a function 
of the level of MEK1 activity that it maintains. Although MEK1 activity has 
been reported to affect actin treadmilling [82], it is not clear how actin 
treadmilling could govern the migration polarity of a cell. The likely 
explanation for this effect of MEK1 activity is that MEK1 activity is 
important for maintaining cell polarity during migration. We are currently 
investigating the biochemical mechanism behind MEK1 dependent 
suppression of cellular turning. Nevertheless, our experiments show that 
MEK1 activity is required for individual cells to migrate with high persistence 
and for groups of cells to migrate collectively.  
 
Migration Persistence is a Required Feature of Collective Migration 
 Even though we are still currently investigating the mechanism by which 
MEK1 activation causes suppression of cellular turning, this phenomenon 
could explain why MEK1 activation leads to collective migration in certain 
circumstances, such as in epithelial sheets and monolayers (Figures 3.3C, 
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3.5C, 3.7A and C, and 3.8B). We propose that individual cellular migration 
persistence is a cause of, rather than a consequence of, collective migration. 
To support our claim, we found that colonies of HaCaT cells do not migrate 
collectively, but do exhibit increased migration persistence upon MEK1 
activation (Figure 3.16A and B). In this case, cells within a colony appear to 
follow the lowest resistance path, which is away from the colony’s center. As 
a result, the expanding colony does not display collective migration. When the 
same cells are arranged in an epithelial sheet, the lowest resistance path for all 
cells is likely to lead into the wound. In this case, independently persistent 
cells are likely guided by resistance into parallel paths. Thus, collective 
migration may be a spontaneous result of persistently migrating cells that are 
presented with only a single low resistance path. The implications of such a 
model is that collective migration is not as “collective” as previously 
described, where the polarization of one cell elicits the polarization of the cell 
behind it in the group [3, 4, 112].  Instead, our model emphasizes that the 
combination of migration persistence and guidance by resistance for each 
individual cell can completely explain the collective migration that we 
observe, where the importance of cellular junctions is much lower than 
previously thought.  
 
Novel Insights into MEK1 Inhibition in Chemotherapy 
Although MEK1 inhibitors are likely to effectively suppress cancer 
metastasis by blocking the persistent migration behavior of both individual 
cells and groups of collectively migrating cells, this chemotherapeutic 
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approach of complete MEK1 inhibition will require strong delivery of high 
doses of MEK1 inhibitors to the tumor site. Our data suggests that low doses 
of MEK1 inhibitors might be more effective in preventing metastasis. In 
Figures 3.8 and 3.15, we showed that local MEK activation distal from a 
wound leads to increasing cellular density. In the hybrid monolayer 
experiment in Figure 3.8A, we noted that DOX dependent activation of 
MEK1 in the internal band of Tet-CA cells led to the contraction of the region 
with locally high MEK1 activity. We proposed that in this case, MEK1 
activation leads to persistent migration in these cells, which are guided away 
from border cells with low MEK1/migration persistence because cells are 
following the lowest resistant path. However, this experiment provides 
supporting evidence that an effective chemotherapeutic approach might be to 
inhibit MEK1 around a tumor, rather than inside a tumor. In this way, cellular 
migration within a tumor can be used to a therapeutic advantage. If MEK1 can 
be selectively inhibited around a tumor, cellular migration inside a tumor 
could drive tumor density to increase. The resulting dense tumor will not only 
be more easily detected by MRI scanning techniques, but also will experience 
local depletion of nutrients that are required for survival. Although dense 
tumors are likely to be harder to kill with conventional chemotherapeutics, 
clinical studies may show that the local depletion of nutrients in such tumors 
is sufficient to drive nonspecific cell death alone. This novel approach of 
treating tumor progression by using cell migration as a weapon against cancer 
seems attractive and warrants further investigation.  
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CHAPTER IV 
 
Partners in Crime:  The TGFβ and MAPK Pathways in Cancer 
Progression 
 
INTRODUCTION 
 
A cell must acquire several key characteristics in order to become 
invasively cancerous: proliferation, resistance to apoptosis, evasion of anti-
growth  signals and immune destruction, as well as increased cellular motility  
[113, 114]. The TGFβ and Ras-MAPK pathways have each been implicated in 
all of the cellular processes that a cancer cell must exploit on the path to 
malignancy. However, it is becoming increasingly clear that these pathways 
interact, such that the resulting signal crosstalk contributes largely to the 
acquisition of many of the key characteristics of a cancer cell.  
 The TGFβ signaling pathway regulates differentiation, migration, and 
death during normal development. Mutations to  the  TGFβ  signaling 
pathway are commonly seen in many genetic diseases and cancers  [115-117].   
For example, early lesions in colorectal and pancreatic cancers frequently 
include  mutations  of  the   cell surface TGFβ receptors or Smad transcription 
factors.  However, the role of the TGFβ ligand in cancer progression has been 
somewhat puzzling and paradoxical due to its multiple, often  opposing,  
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effects  on   cell  growth. This TGFβ paradox is best exemplified by the fact 
that TGFβ has  been  shown  to act not only as a tumor suppressor, but also as 
a promoter of tumor growth and metastasis [118, 119]. 
Ras-MAPK signaling has been linked to fundamental cell processes such  
as  differentiation, migration and  proliferation  [120, 121]. The GTPase Ras 
and the Ras-MAPK  cell surface  receptors  that  initiate  the intracellular 
signaling  pathway (EGFR, FGFR, etc.) are often mutated in colorectal and 
pancreatic   cancer, and these mutations   lead   to   a constitutively   active   
Ras-MAPK   pathway   [122].  Once commandeered,   MAPK   transcription 
factor substrates promote unchecked cellular   proliferation, leading to tumor 
initiation. This review will examine the parallels   between   and intersections 
of these two pathways, with emphasis placed on their relevance in colorectal 
and pancreatic cancers.  We will explore how the interactions between these 
pathways contribute to the physiological changes displayed by cancer cells, 
and how these interactions are modulated throughout tumor progression and 
metastasis.  
 
The canonical Ras-MAPK pathway 
The  Ras-MAPK   (Mitogen Activated Protein Kinase) pathway begins 
with growth factor binding to transmembrane Receptor Tyrosine Kinases 
(RTKs) (Figure 4.1).  Growth factor binding initiates homodimerization and 
auto-phosphorylation in trans at specific tyrosines  of  the RTKs  [122, 123]. 
Growth  factor  receptor-bound   protein  2 (Grb2)  is  then  recruited  to  the  
cytosolic  portion  of  the RTKs via a Src homology 2 (SH2) domain which 
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Figure 4.1 A Schematic Diagram of Both Non-Canonical and Canonical TGF-Beta Signaling. In the 
canonical pathway, TGF-Beta receptor activation leads to Smad2/3 phosphorylation and nuclear 
accumulation. In the non-canonical pathway, receptor activation leads to indirect activation of the Ras-
MEK pathway.  
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binds to phosphotyrosines. Grb2   then   recruits   a   guanine exchange  factor,  
Son  of  Sevenless  (SOS),  via  an  SH3 domain   and   the   GTPase   Ras 
[122, 123] . Ras, a protein that was originally identified  as  the  transforming  
component  in  oncogenic viruses, is  then  post- translationally   modified   
with   an   isoprenyl  group   that localizes it to the plasma membrane [114, 
124].  The GTPase activity  of  Ras  is  enhanced  by  the  GTPase  Activating 
Protein  (GAP).   Ras recruits and activates the MAPK  kinase  kinase 
(MAPKKK)  Raf  which  initiates  a phosphorylation cascade from Raf to 
MEK (MAPKK) which  finally  phosphorylates  ERK  (MAPK, Extracellar 
Regulated   Kinase). Phosphorylated   ERK then translocates  to the   nucleus   
where   it   phosphorylates transcription factors    important   for   proliferation   
and differentiation [122, 123].   
The regulation of the activity and the specificity of MAPKs is critical for 
proper function  and accurate transduction  of  extracellular  signals. ERK  is  
deactivated  by  MAPK phosphatases, resulting in a pathway that can 
terminate signaling in the absence of upstream stimuli [125]. The binding  
sites  on  ERK,  auxiliary  to  the substrate  recognition  motif  in  the  active  
site  of  ERK, confer   the specificity  for  substrates  [126].  Recent studies 
indicate that scaffolding proteins may play  an  important role  in  the  timing  
and   the amplitude  of  Ras-MAPK  signaling by regulating the location of 
MAPK  components [127].   The scaffold either sequesters them to the cytosol 
and delays a response or facilitates a faster  phopsphorylation  cascade  
through the spatial concentration of the kinases (Figure  4.1), as has been 
shown for the scaffolding protein KSR (Kinase Supressor of  Ras) [127, 128]. 
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 The canonical TGFβ pathway 
TGF-β signals through two receptor types, the TGF-β type I and type II 
receptors (TβRI and TβRII, respectively) [69]. Both receptors are Ser/Thr 
kinases.  While the type II receptor is constitutively active, the type I receptor 
is inactive in the absence of ligand[129].  TGF-β can bind the type II receptor 
independent of the type I receptor [130].  Upon binding of the ligand, TGF-β 
induces oligomeric receptor complex formation which enables the type II 
receptor to phosphorylate the type I receptor in the GS domain and 
consequently cause a conformational change and release of inhibitory 
molecules such as FKBP12[129, 131].  Activated TβRI recruits and 
phosphorylates Smad2 and Smad3 (R-Smads), a process that is aided by 
SARA (Smad Anchor for Receptor Activation)[132, 133].  Phosphorylation of 
the R-Smads causes a conformational change such that the R-Smad is released  
from  SARA [132]. Phosphorylated  R-Smad  binds Smad4 forming a R-
Smad/Smad4  complex, as well as forming homo-oligomeric complexes, 
which translocate to the nucleus and directly interact with DNA, resulting in 
the   recruitment of   coactivators   or   chromatin    remodeling components 
[134].The recruitment of coactivators, corepressors and    chromatin    
remodeling   components determines the ultimate Smad dependent cellular 
response to the ligand stimulation [134]. TGF-ß regulates the transcript levels 
of approximately 100-300 genes in various cell types (Figure 4.1) [1-3].  
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The Non-canonical TGFβ pathway 
Activation of Smads by TGF-ß is invariant in most cell types and therefore 
this  pathway is known as the canonical TGF-ß pathway.  Beside activation of 
Smads, TGF-ß also modulates the activity of several other signaling pathways 
in a ligand and receptor dependent manner (e.g. MAP kinase (MAPK) 
pathways, Rho-like GTPase signaling pathways, and phosphatidylinositol-3-
kinase (PI3K)/ AKT pathways [80, 135, 136]).  Unlike the canonical pathway, 
modulation of these pathways by TGF-ß is often cell type specific and context 
dependent [137].  They are collectively referred to as non-Smad or 
noncanonical TGF-ß signaling pathways.  Although canonical TGF-ß 
signaling through Smads dominated the field of TGF-ß research over the last 
decade, there has been increasing attention paid to the noncanonical TGF-ß 
signaling, particularly in the context of cell migration and epithelial-
mesenchymal transition (EMT).  In mammalian cells, all three MAPKs are 
activated by TGF-ß (Figure 4.1) (Each MAPK has different isoforms and, for 
simplicity, they are generically referred as Erk, JNK and p38). However, the 
kinetics of these activations vary with cell types and culture conditions [75, 
78, 80, 135, 136].  The upstream signal transducers to MAPKs are likely small 
GTPases (Ras, Rac, RhoA and Cdc42) [75, 80, 135, 136].  Their activities are 
frequently regulated by TGF-ß through diverse mechanisms. Here, we will 
focus on the Ras-MAPK pathways.  For detailed discussions on the various 
noncanonical or non-Smad TGF-ß pathways, please refer to several excellent 
reviews on this topic [80, 135, 136, 138].    
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It has been known for some time that TGF-ß rapidly activates Erk MAP 
kinases through Ras, but the magnitude of the resulting activation of Erk1/2 is 
much lower compared the activation by RTKs [78].  One mechanism that has 
been identified involves phosphorylation of ShcA by the  TGFβ  receptor  
complex on the tyrosine residues of ShcA.  Similar to the RTK signaling, 
ShcA phoshotyrosines recruit the Grb2/SOS/Ras complex which  
subsequently   trigger the activation of   the   Ras-MAPK pathway (Box 1, 
Figure 4.1) [139].  The biological significance of intrinsic activation of Ras-
MAPK by TGFβ in normal cellular process is still poorly understood.   Gene 
expression profiling studies implicate that  TGF-β-stimulated Erk activation is 
involved in the modulating of a subset of genes that figure prominently in cell 
motility and cell-matrix interaction [140].  Some of the genes are often 
associated with epithelial to mesenchymal transition (EMT), an indispensable 
mechanism for producing mesenchymal cells, tissues and organs during 
normal development [141-143].  Thus, the intrinsic, relatively low, activation 
of Ras-MAPK is likely crucial for specific induction of genes regulating EMT 
and cellular motility.      
 
Signaling Crosstalk Between the Ras-MAPK and TGFβ pathways 
The integration of  Ras-MAPK and TGFβ pathways can occur via 
balanced activation of both canonical and noncanonical TGFβ pathways by 
TGFβ alone, through simultaneous stimulation of TGFβ and ligands of other 
signaling pathways that modulate the activity of Ras-MAPK, or through 
crosstalk via interactions between the intracellular effector proteins distinct to 
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each of the two pathways. In the two lattermost mechanisms, there are two 
common points of integration of the Ras-MAPK and TGFβ  pathways: 1) 
phosphorylation of coactivators of R-Smads by Erks,  2) phosphorylation of 
Smad2/3 by Erks in the linker region.  Most of the TGFβ signaling responses 
are cell context dependent  [137]. The cell type specific responses are in part 
due to Smad interaction with cell type specific transcription factors [134].  For 
example, activated Smad3 binds its cognate sites with Oct4 in embryonic stem 
cells (ESCs), MyoD in myotubes and PU.1 in pro-B cells [134].  The 
association between activated Smad2/3 and transcriptional cofactors can be 
regulated by the Ras-MAPK pathway.  For example, Ras-MAPK activity has 
been shown to regulate the interaction of p53 and Smad2/3. In this 
mechanism, FGF signals through Ras-MAPK to regulate p53 phosphorylation 
at its N-terminus (Ser6 and Ser9) by CK1 ϵ/δ [144].  Such phosphorylation of 
p53 enables its interaction with activated Smad2/3 to regulate target genes that 
are important for TGFβ cytostatic program [144].  Similarly, Src-activated 
Epidermal Growth Factor Receptor (EGFR) signals through Ras-MAPK to 
engender phosphorylation of the E-box binding transcription factor USF and 
facilitate its interaction with activated Smad2/3 to regulate PAI-1 gene 
expression [145]. Thus, the RTK activated Ras-MAPK pathway converges 
with the canonical TGFβ pathway at chromatin  in order to regulate gene 
expression.  
Ras-MAPK has also  been  shown  to phosphorylate R-Smads auxiliary to 
the activation regions[146, 147], sequestering  them to the cytoplasm to 
attenuate TGFβ signaling [147].  However, the opposite effect of activated 
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Ras-MAPK on Smad activity has also been reported [148-150].  A possible 
explanation for the contradictory observations is that the levels of Ras activity 
could dictate the outcome of the experiment [151].  In a majority of human 
cancers carrying oncogenic Ras mutations, the activity rather than the levels 
of Ras expression is elevated.  Thus, the levels of Ras activity translate into 
the levels of MAPK activity, ultimately shaping the TGFβ response via 
crosstalk between R-Smads and the Ras-MAPK pathway.   
The linker region between Mad Homology Domains 1 and 2 (MH1 and 
MH2) have been shown to be phosphorylated by GSK-3 and ERK1/2. 
Phosphorylation of Ser204 on Smad3 via GSK-3 kinase activity results in 
decreased affinity between Smad3 and CREB binding protein, suggesting that 
the functional significance of the linker region phosphorylation status is to 
modulate transcription factor activity of SMAD proteins, rather than to 
regulate the nucleocytoplasmic localization of Smad proteins[152]. Consistent 
with this theory, the linker region phosphorylation of Smad2 and Smad3 by 
ERK1/2 at positions Ser240/Ser245/Ser250 and Ser204/Ser208/Ser215, 
respectively, has been shown to enhance Smad transcriptional activity of the 
Type I and Type III Collagen gene [148, 153]. Additionally, Small C-terminal 
Phosphatase (SCPs) in the nucleus have been shown to dephosphorylate the 
linker region phosphorylation sites in Smad2, confirming a primarily nuclear 
role of the linker region phosphorylation [154]. Such dephosphorylation by 
SCPs results in activation of Smad dependent transcriptional regulation of 
exogenous luciferase reporters[154]. Thus, conflicting results about the 
functional consequences of linker region phosphorylation suggest that not 
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only is Smad2/3 transcriptional activity regulated in a cell type specific 
manner, but also perhaps in a single cell type discrete genes are positively or 
negatively regulated by linker region phosphorylation in a chromatin context 
dependent manner. Taken together, the current and previously reported data 
strongly suggests that different cellular responses to TGFβ stimulation in 
different cell types and cellular contexts largely results from the status of 
MAPK activity at the time of ligand stimulation. 
 
Systems Features of MAPK and TGFβ  pathways 
Even though the signaling  of  the  TGFβ  and  Ras-MAPK  pathways 
initiates upon  ligand binding at the plasma membrane,  the modes of signal 
transmission are quite different [155, 156].   The Ras-MAPK pathway features 
a cascade of sequential kinase phosphorylations/activations from RAF to ERK 
(Figure 4.1).  This type of pathway architecture can lead to significant 
amplification of the original upstream receptor/ligand binding signal.  The 
RTKs also activate other signaling pathways such as PLCγ, PI3K or Src.  
Some of these signaling pathways can feed into Ras-MAPK and produce 
positive feedback loops. There are also multiple well characterized negative 
feedback loops in the Ras-MAPK pathway that cause desensitization or 
dampening of the signal [157].   The presence of these feedback loops have 
been shown to produce switch-like (i.e. bistable)  responses to receptor 
activation, allowing for a tight threshold of cellular response during 
development [158, 159]. 
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 Unlike the Ras-MAPK pathway, the TGFβ  signal relay system is 
relatively short.  There are no apparent signal amplification steps in the 
signaling cascade subsequent to the receptor phosphorylation of R-Smads.  
The constant shuttling of Smads in and out of the nucleus allows the Smads to 
constantly monitor receptor activity [156].  This type of arrangement results in 
a more linear response to ligand binding.  However, a more recent study 
reveals that TGFβ depletion during signaling is important to produce 
threshold-like input/output response to receptor activation [160]. Clearly, 
there is also nonlinearity in the TGFβ pathway.  
Systems analysis of biological signaling pathways suggests that signaling 
pathways interact with one another and the final biological response is shaped 
by interaction between pathways [159].  Since there are multiple integration 
points between the Ras-MAPK and TGFβ pathways, it is not a surprise that 
the integration of these two pathways produces quite complex biological 
outcomes, depending on the cellular context. The challenge is how to 
precisely determine the behaviors of the interacting pathways and how to 
manipulate the end-point biological responses in normal and cancer cells.   
 
Lesions in the Ras-MAPK  and  TGFβ pathways  in  Cancers 
Colorectal  and  pancreatic  cancers   are, respectively,  the  fourth  and  
fifth  causes of cancer  deaths [161].  More  than  one  third  of  colorectal 
cancer  patients   develop   metastasis. Of   these cancers,  about 35%  are the 
result of genetic predisposition due to  inherited  lesions  in  the  TGFβ  
pathway [162].  Additionally, mutations that inactivate the key signal 
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components, including receptors and Smads, are frequently observed within 
the tumor.  Loss of function mutations in TβRII have been found in a majority 
of colorectal and gastric carcinomas with microsatellite instability (MSI) [163, 
164].  In microsatellite stable colon cancer cell lines, missense mutations are 
identified in ∼15% of cases [165].  Inactivating mutations of TβRI occurs at 
low frequency in pancreatic and biliary carcinomas [166] but relatively high 
in ovarian cancers with wild type TβRII [167]. In one example of  TGFβ  
pathway lesion, TGFβRI*6A, the TGFβRI is  missing  three  alanines from  
the  signal  sequence. TGFβRI*6A  was  previously  associated  with  
hereditary cancers based on analysis of a limited  numbers of cases [168, 169].  
Recent work using a much  larger number of case studies suggests that there is 
no increased hereditary risk of colon cancer associated with this mutation 
[170]. However, it is still possible that TGFβRI*6A does convey increased 
risk  in specific patient populations or in somatic mutations [170]. 
Inactivation of TGF-β signaling also occurs by disabling Smad proteins.  
SMAD4 was originally identified as a tumor-suppressor gene lost in 
pancreatic cancers called DPC4 (deleted in pancreatic cancer 4) [171].  
Subsequent studies revealed that deletion of Smad4 also occurs in 16–25% of 
colorectal cancer [172].   Germline mutations of SMAD4 are associated with 
juvenile polyposis and hamartomatous polyposis [173, 174].  Inactivating 
mutations of Smad2 have been identified in ∼6% of colorectal cancers while 
loss of function mutations of Smad3 are rare in colorectal cancers [172, 175].   
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Escaping the TGFβ growth constraint is one of the hallmarks of tumor 
cells [114]. Tumor cells explore different mechanisms to achieve this.  
Despite the fact that inactivating mutations in the canonical TGFβ pathways in 
colorectal and pancreatic tumors are wide spread, cells isolated from other 
tumor types preserve the functionality of the canonical TGFβ signaling 
components and achieve TGFβ growth resistance by altering other aspects of 
the pathways [117].  Thus, oncogenic activation can also interdict TGFβ 
growth inhibitory responses by modifying the activity of downstream 
elements such as cell cycle inhibitors or transcriptional cofactors of Smad 
transcription factor activity.   
 Throughout tumor progression, the TGFβ   ligand   becomes   highly   
expressed   and actually promotes proliferation, particularly in the case of 
prostate cancer [176].    This may be due to  its ability to stimulate MAPK 
pathways [177].  High levels of TGFβ  are  correlated  with  increased  
angiogenesis,  as  the tumor recruits blood vessels to allow for greater growth 
by inducing greater TGFβ dependent VEGF expression [178].  In the clinic, 
patients with high  levels of TGFβ  have decreased survival, likely due to  
aggressive tumor progression and metastasis [179]. In   addition to over 
secretion of the TGFβ ligand, deregulation of the intracellular pathway can 
sensitize cells to an unchanging amount of TGFβ ligand.  For example, in situ 
cell culture RNAi  knockdown  of  Phosphatase  and  Tensin  Homolog  
(PTEN),  a  TGFβR phosphatase,  resulted in the increased TGFβ dependent 
invasion potential of cells [180].  Recent studies also suggest that TGFβ  is  
involved, in some cell types, in directing metastatic cells to specific locations 
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such as bone [181, 182].   The cellular response to TGFβ in tumors clearly 
plays a role in tumor metastasis, even though there is not strong evidence that 
R-Smads mediate this role. 
The  Ras-MAPK  pathway  is  an  important  component  of many   
cancerous   cells.  The majority of cancer associated lesions to the Ras-MAPK 
pathway result in constitutive activation of the pathway [124]. Mutations  
that  have  been  identified  are located early in the pathway and include 
overexpression of RTKs, activating mutations to RTKs, sustained expression 
of activating autocrine or paracrine ligands, and mutations to Ras and Raf 
[114, 124].  Temporally, these lesions occur early in tumorigenesis and are 
sustained for the life of the cancer (Figure 4.2).  Ras mutations have been 
found in 30% of all cancers, 90% of pancreatic   cancers   and   50%   of   
colon   cancers [124].  B-Raf  mutations  have  been  found  in  65%  of 
melanomas, 45% of papillary thyroid cancers  and 36% of ovarian cancer 
[183-185].  In summary, a large portion of human tumors have a constitutively 
active Ras-MAPK pathway and have acquired resistance to TGFβ induced cell 
cycle arrest.  Thus, the role of TGFβ in cancer progression seems to be largely 
through lesions that stimulate the non-cannonical signaling, and are aided by 
inactivating lesions in the canonical pathway, which are associated with cell-
cycle arrest and the apoptotic response. 
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Figure 4.2 A Schematic Diagram of the Role of TGF-Beta and MAPK Activities in Cancer 
Progression. TGF-beta activity is elevated in the late stages of cancer progression, while MAPK activity 
is elevated in the early stages of cancer progression. 
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Crosstalk between TGFβ  and  Ras-MAPK Signaling Pathways drives 
EMT 
Crosstalk between the TGFβ and Ras-MAPK pathways appears to be 
required for tumor metastasis, likely through the role of crosstalk in epithelial-
mesenchymal  transition  (EMT). TGFβ induced EMT, which is a fundamental 
mechanism that drives  metastasis  in   vivo  or invasion  in  vitro,  requires  
constant TGFβ  signaling  to  become  a stable phenotype [186, 187].  The 
connection between EMT and metastasis is exemplified through the finding 
that fibroblast cells that undergo EMT are more conducive to promote tumor 
invasion [188]. EMT is marked  by  changes  to  the actin cytoskeleton,   loss   
of   cell   polarity,   and migration/invasion [143, 189].  Acting alone, neither 
pathway  is successful  in  permanently  converting from  an  epithelial  to  a   
mesenchymal  phenotype [149]. Long-term expression  and cooperation of 
TGFβ and Ras- MAPK  causes  full  EMT  through  induction  of  cytokine 
feedback loops  that  include upregulating TGFβ autocrine signaling [186].  
Recently, a new mechanism by which TGFβ induces EMT has been 
introduced, where TGFβ induces isoform switching of fibroblast growth 
factor (FGF) receptors [188].  Prolonged treatment of TGFβ results in 
increased FGFR1IIIc, which is the mesenchymal isoform, and decreased 
expression of the epithelial isoforms of FGF receptors.  FGF-2 but not FGF-7 
signals through FGFR1IIIc[188]. The switch in FGF-2 receptor expression 
enables cells to respond to FGF-2 to activate Ras-MAPK.  Furthermore, 
epithelial cells treated with both TGFβ and FGF-2 undergo EMT instead of 
epithelial to   epithelial–myofibroblastic transition (EMyoT).  Thus, the 
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crosstalk between  the  Ras-MAPK and TGFβ pathways may be harnessed to  
promote tumor growth through EMT.   
 
Conclusions and Future Directions 
Colorectal  and  pancreatic  cancers  account  for  a   large portion  of  
cancer  incidence  and  fatalities  in  the  United States.   Thus, they are 
important models for the   study of the complicated roles of Ras-MAPK and 
TGFβ pathways.  As more  is  learned  about  these  pathways   in  normal  
and cancerous   cells,   it   becomes    increasingly   clear   that crosstalk 
between the distinct pathway components are important  for   TGFβ signal 
interpretation in a cell type and cell context dependent manner.  Future studies 
are required to address the interdependency of these pathways, paying close 
attention to the connection between the cellular context in a study, the level of 
contribution of the Ras-MAPK pathway to the TGFβ response, and the 
ultimate cellular response to TGFβ ligand stimulation.     
A consequence of this emerging theme of crosstalk may be the 
reevaluation of  cancer therapeutic strategies.  Currently, Ras and Raf have 
been the hot targets in the Ras-MAPK pathway for anticancer drugs.  
Inhibition of isoprenylation of Ras  seemed  promising. However, it appears  
that  the enzymes   that   catalyze   this    reaction    are   somewhat 
promiscuous   and   off-target   effects   have   limited   the successful 
development  of  inhibitors  of  Ras.  Other   Ras-MAPK components 
such as Raf, MEK and ERK  are also being investigated and are proving more 
successful drug targets [190].  One drug targeting Raf has been approved by 
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the FDA for treatment of renal cell carcinoma and a handful of other drugs are 
in Phase I/II/III trials that  target Raf and MEK [190]. TGFβ’s involvement in 
promoting a metastatic phenotype in aggressive  cancers   makes  it  a  highly  
sought  after pathway to target  for anticancer  therapies.   The obvious targets 
of  choice  are the TGFβ  ligand itself, the ligand- binding   surface   on   
TGFβRI/II   and   betaglycan [191].  As a result, a humanized anti- TGFβ 
monoclonal antibody (GC1008) is in Phase I/II clinical trials.  Additionally, 
soluble  TGFβRII   and  betaglycan  recombinant receptors, which compete 
for extracellular TGFβ, as  well as   inhibitors    TGFβRI    kinase   activity    
have    shown encouraging anti-metastatic results [192].  As might be the case 
for many kinase inhibitors, long term administration of a single agent may 
select for more aggressive drug resistant tumor variants, as has been 
demonstrated for LY2109761, a TβRI/TβRII kinase inhibitor in a mouse skin 
model [193].   Considering the synergistic effects of  TGFβ  and  MAPK  
pathways in tumorigenesis it is logical to try a  combinatorial approach in 
cancer treatments, where simultaneous partial inhibition of the Ras-MAPK 
and TGFβ pathways, yields synergistic inhibition of TGFβ ligand induced 
metatstasis, while having minimal impact on other aspects of TGFβ and Ras-
MAPK biology. 
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 CHAPTER V 
 
Dynamics of TGF-β/Smad Signaling 
 
INTRODUCTION 
 
The Basics of Transforming Growth Factor-β Signaling 
TGF-β is the prototypical ligand of the TGF-β superfamily, which signal 
through receptor serine/threonine kinases. The superfamily is subdivided into 
two branches: (1) the TGF-β/Activin branch and (2) the Bone Morphogenetic 
Protein (BMP)/Growth and Differentiation Factor (GDF) branch. Each branch 
is further divided into subgroups based on sequence similarity [69]. The TGF-
β/Activin branch includes TGF-β, Activin, Inhibin, Nodal, and Lefty ligands. 
The BMP/GDF branch includes BMP, GDF, and Mullerian Inhibitory 
Substance (MIS) ligands. This review will focus on the quantitative analyses 
of TGF-β signaling, which is the most studied ligand in terms of basic signal 
transduction mechanisms. There are also substantial quantitative studies of 
BMP signaling, especially in the context of morphogen gradient formation 
and interpretation which have been covered in several excellent reviews [194-
197].  
TGF-β is expressed in most cell types and is translated into a proprotein 
that is proteolytically cleaved into a noncovalently linked mature TGF-β and 
latency-associated protein (LAP) [198, 199]. The active TGF-β ligand is a 25 
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kDa dimer, covalently linked by a disulfide bond between cysteine residues 
from each monomeric peptide. When bound to LAP, TGF-β cannot bind to its 
receptors, resulting in a ligand that lacks bioavailability. Its bioavailability is 
further restricted by binding to another protein called Latent TGF-β Binding 
Protein (LTBP). The LAP-TGF-β complex is bound by LTBP during the 
secretion process [198]. LTBP binds the extracellular matrix and sequesters 
LAP-TGF-β in vivo [198]. Various proteases cleave LAP and LTBP to 
liberate the bioactive TGF-β [8]. Bioactive TGF-β can bind various non-
receptor cell surface proteins such as decorin, biglycan, and betaglycan, which 
also serve to regulate its bioavailability, most likely through the enrichment of 
TGF-β at the plasma membrane [198, 199]. Therefore, multiple mechanisms 
serve to regulate the bioavailability of TGF-β in vivo. 
Once bioavailable TGF-β reaches the surface of the target cell, it binds a 
homodimer of TGF-β type II receptors (TβRII) [69]. The TGF-β-TβRII 
complex provides a structural interface that facilitates stable complex 
formation with a homodimer of the TGF-β type I receptor (TβRI) [132]. 
Therefore, the active ligand-receptor complex is a heterotetrameric complex 
consisting of a dimer of TGF-β and homodimers of both TβRII and TβRI. 
Within the active receptor complex, the TβRII, which is a constitutively active 
kinase, undergoes autophosphorylation, as well as catalyzes 
transphosphorylation of the TβRI [132]. Transphosphorylation of the TβRI 
activates kinase activity. In the TGF-β pathway, Smad2 and Smad3 are 
receptor-regulated effector proteins (R-Smads), which are phosphorylated by 
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the activated TβRI at a C-terminal SSXS motif, resulting in R-Smad nuclear 
accumulation [132].  
TGF-β signaling amplitude and duration can be regulated through the 
control of receptor trafficking. The ligand bound activated receptor complex is 
internalized via endoytosis [200]. Internalization of cell surface receptors can 
occur through either clathrin-mediated or caveolae-mediated endocytosis 
[201]. Through the clathrin pathway, activated ligand-receptor complexes are 
brought into early endosomes which are enriched with scaffold proteins such 
as SARA and Hrs [200]. The proximity of the activated receptor complex and 
scaffold proteins enhances the phosphorylation of Smad2/3 and their affinity 
towards Smad4, ultimately activating the nuclear accumulation of Smad4 
(also known as the co-Smad) [202]. Therefore, clathrin-mediated endocytosis 
may promote TGF-β signaling by providing a platform for R-Smad 
phosphorylation and formation of active Smad signaling complexes. Ligand-
bound receptor complexes in the early endosomes are further sorted to late 
endosomes, where TGF-β and the receptors are separated. Some of the 
unbound receptors can be recycled to the plasma membrane, while others are 
degraded, along with TGF-β, upon fusion with the lysosomes [201]. Since 
TGF-β is not recycled, internalization of TGF-β by endocytosis is the primary 
means of removing active TGF-β from the cell surface, and lysosomal 
degradation is the primary means of termination of TGF-β signaling [203, 
204].   
Activation of TGF-β receptors initiates both Smad-dependent and Smad-
independent signaling events [135, 136, 205]. Since the majority of the 
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quantitative studies of TGF-β signaling have focused on Smad-dependent 
events, we will focus our discussion on the dynamics of the canonical 
pathway (Smad-dependent). In unstimulated cells, Smads constitutively 
shuttle between the cytoplasm and nucleus. Upon ligand stimulation, the 
Smads accumulate in the nucleus as the R-Smad/Co-Smad complex formation 
leads to a decrease in their nuclear export rate [155, 206, 207]. The Smad 
complex binds DNA in conjunction with other transcription factors and 
interacts with the general transcription machinery to regulate the expression of 
approximately 100-300 target genes [202]. Phosphatase(s) such as PPM1A 
can deactivate phospho-R-Smads, resulting in the disassembly of the Smad 
complex and providing a means for negative regulation of TGF-β signaling in 
the nucleus [155]. Therefore, the intracellular Smad signaling module is a 
dynamic circuit for ligand sensing.  
 
 Mathematical modeling of the TGF-β signaling pathway 
Conventional cell signaling studies have largely focused on understanding 
the identity and the functions of the individual parts of each pathway. It is 
now realized that cell behaviors are not only shaped by the identity of the 
individual system components, but also by the weighted interactions of 
components that act together as a system. The systems biology approach using 
mathematical models has been proven as a powerful tool in studying such 
complex networks [208]. Mathematical modeling is helpful in predicting 
emergent cell behaviors and uncovering how the dynamic interactions of 
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signal transducers lead to context dependent cellular responses [209]. Several 
mathematical models have been established for the canonical TGF-β/Smad 
signaling [204, 206, 210-217]. These mathematical models provide 
quantitative analyses of TGF-β signaling dynamics, leading to a better 
understanding of the role of feedback mechanisms in the ultimate fate of 
context dependent signaling responses.  
The most common way to describe TGF-β signaling dynamics is through a 
set of deterministic ordinary differential equations (ODEs), assuming the 
signaling molecules are well-mixed or homogenous in each compartment 
[208]. The ODEs represent the change of each signaling molecule over time. 
In order to perform simulations and predictions (modeling), it is necessary to 
know the values for two types of model parameters: the initial conditions of 
the pathway that correspond to the concentrations of the signaling molecules 
at time 0 (before TGF-β stimulation) and the rate constants that characterizes 
the signaling reactions. The principal molecular components of TGF-β 
signaling have been identified, yet relatively little is known about the 
quantitative values of particular components’ abundance and rate constants. 
The lack of experimental data on initial conditions and rate constants is 
currently one of the bottlenecks for developing high-quality predictive 
mathematical models for signaling networks. 
Different approaches have been applied to estimate the model parameters. 
The initial conditions of the signaling network can be determined by the 
absolute abundance of the signaling proteins and the volume of the signaling 
compartment. It is possible to estimate the absolute abundance of a signaling 
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protein when the recombinant protein is available. For example, the absolute 
abundance of Smad2 protein per cell can be quantified by immunoblotting 
with a standard curve of recombinant tagged-Smad2 [218]. Cell volume is 
sometimes roughly estimated from cell diameter or it can be measured more 
accurately by confocal microscopy [219]. On the other hand, direct 
measurement of the rate constants for different signaling reactions is still 
experimentally challenging. In order to estimate the unknown model 
parameters, optimization algorithms are applied to find the most feasible 
parameters that make model simulations fit the experimental datasets as close 
as possible [220, 221]. During the past few years, some quantitative data has 
been experimentally measured for the TGF-β signaling pathway, aiding the 
modeling efforts for this network [201, 204, 207, 213]. Figure 1 summarizes 
our current knowledge about the model parameters for the canonical TGF-
β/Smad signaling network.  
 
Quantitative analysis of signaling responses to different TGF-β 
stimulations 
The cellular responses to TGF-β superfamily ligands depend on the 
quantity to which the cells are exposed. In development, TGF-β superfamily 
members form morphogen gradients to determine the fates of cells [194]. 
Cells read the TGF-β concentration with high precision, as they can 
distinguish subtle differences in the concentration gradients and orchestrate 
different cell fates [222]. One of the best examples is the responses of 
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embryonic Xenopus cells to activin, in which five distinct cell responses or 
fates are observed by varying activin doses [222]. However, the mechanism 
by which cells are able to accurately decode the concentration of bioavailable 
TGF-β and elicit a corresponding cellular response remains largely unknown. 
 
The Smad signaling response correlates with TGF-β molecules per cell 
rather than the concentration of TGF-β 
An early study with mathematical models has shown that cell density 
affects signaling dynamics in response to the same concentration of ligand 
[223]. Through modeling analyses of receptor trafficking networks, Zi et al. 
showed that with the same concentration of ligand stimulation, cells have 
distinct signaling durations that depend upon cell density, where signaling 
persists longer when cell density is decreased [223]. Additionally, the model 
analyses indicate that the dose–response curve of signaling is shifted to the 
right as the cell density is increased, suggesting that increasing cell density 
allows for insensitivity to lower doses of ligand. Thus, the key parameter for 
successful experimental design cannot be “concentration of ligand”, but rather 
must be “molecules of ligand per cell”, which takes into account the number 
of cells in the experiment. Further model simulations indicate that signaling 
responses are regulated by the ratio of ligand to cell surface receptor number 
[223]. In cell culture experiments, individual cells are likely to express 
different amounts of receptors at cell surface. Thus, when all cells are exposed 
to the same amount of ligand, the ratio of ligand to cell surface receptor 
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number in each cell will be different, which might cause heterogeneous 
signaling responses at single cell level.  
To provide additional evidence that cellular responses to ligand occur in 
terms of “molecules  per cell” rather than by the concentration of the ligand, 
Clarke et al. investigated how cells transduce TGF-β doses into variable 
kinetic profiles of Smad2 phosphorylation at C-terminal motif (P-Smad2) by 
quantitative experimental assays [203]. Clarke et al. measured P-Smad2 levels 
in a two-level factorial experiment by varying four experimental parameters 
(TGF-β concentration, cell number at seeding, plate type, and medium 
volume). When the P-Smad2 data is plotted versus TGF-β concentration, large 
variations are observed for the same TGF-β concentration among different 
experimental setups. In contrast, the variation of P-Smad2 levels is 
significantly reduced if these levels are plotted versus the number of TGF-β 
molecules per cell. This result implies that the ligand dose expressed as TGF-
β molecules per cell is a better predictor of P-Smad2 levels, which is in 
agreement with early modeling studies about the impact of cell density on 
signaling response.  
Ligand depletion in the TGF-β network provide additional complexity and 
increases the difficulty of predicting the time dependent signaling responses. 
For example, the number of TGF-β molecules per cell in the media changes 
substantially with time because the cells deplete TGF-β from the surrounding 
medium. It was shown that TβRII defective, but not TβRI defective, cell lines 
lost their ability to deplete TGF-β from the media [203]. Thus, TβRII helps to 
shape the Smad signal amplitude and duration by constitutively depleting 
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extracellular TGF-β. TGF-β depletion most likely occurs through TβRII-
mediated endocytosis. However, direct evidence that supports this notion 
remains to be presented in the literature. In this aspect, TGF-β degradation 
shares many similarities to EGF or TGF-α [224, 225] in that ligand-induced 
endocytosis does not merely serve as a mechanism for “down-regulation” of 
signaling, but also provides a mechanism whereby the receptor can 
continuously track the changes in the secretion of TGF-β by nearby cells. It 
should be noted that most studies of TGF-β signaling assume that TGF-β 
concentration in the medium is sufficient to describe the input variable 
(potency of ligand). Consequently, most modeling studies have assumed a 
constant level of TGF-β during signaling over time. However, in cell based 
experiments TGF-β concentration in the medium changes substantially with 
time, especially for low doses of TGF-β. Therefore, the assumption that TGF-
β concentration is constant in medium might be appropriate for high doses of 
TGF-β, but it is invalid for low doses of TGF-β.  
 
TGF-β dose-responses are time dependent  
Earlier experimental and modeling analyses showed that Smad signal 
amplitude is gradually increased with the increments of TGF-β doses [211, 
212, 226]. This leads to an important question about how cells convert 
continuous TGF-β doses into discrete or binary cellular fate decisions. Since 
most of modeling studies in the TGF-β field do not account for the TGF-β 
input variable by assuming constant TGF-β concentration in medium, this 
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omission often results in unreliable predictions of Smad signaling kinetics in 
response to variable doses of TGF-β stimulation [204]. Recently, we 
developed an improved mathematical model to describe the dynamics of 
Smad signaling in response to TGF-β [204]. The model was composed of 
TGF-β receptor trafficking, Smad phosphorylation and Smad 
nucleocytoplasmic shuttling. More importantly, it took into account the 
dynamics of TGF-β depletion. Model parameters were estimated by model 
fitting to several time course datasets, which include variables of TGF-β 
depletion in the medium, Smad2 nuclear localization and P-Smad2 dynamics. 
The model was further tested for its ability to predict the P-Smad2 signaling 
upon pulsation of TGF-β stimulation. With this data-calibrated model, novel 
predictions were made through model simulations. It was shown that TGF-β 
signaling responses display different sensitivities to ligand doses at different 
time scales [204]. In this study, modeling simulations and experimental results 
show that while short-term P-Smad2 is graded, long-term P-Smad2 response 
is switch-like to changes in TGF-β doses (Figure 2). In the short-term graded 
response, P-Smad2 signal gradually increases with rising increments of TGF-
β dose. In the long-term switch-like response, a small change of TGF-β dose 
within a certain range results in a large change in P-Smad2 response. 
Furthermore, a switch-like response is observed for TGF-β induced long-term 
gene expression and growth inhibitory responses. Additional model 
perturbation experiments predicted that the switch-like, long-term P-Smad2 
response is mainly affected by the parameters related to the ligand depletion. 
This prediction was experimentally confirmed [204].  
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 The TGF-β pathway is insensitive to high frequency noise  
While extensive studies have focused on signaling responses to continuous 
TGF-β stimulations, little is known about how cells respond to short pulses of 
TGF-β stimulations. Taking advantage of model simulations, Zi et al. have 
shown that short-term TGF-β pulse stimulation results in transient P-Smad2, 
whereas serial pulses result in sustained P-Smad2, similar to that seen with 
continuous stimulation [204]. To generate a sustained response, the gap 
between repeated pulse stimulation is ~30 min. This result suggests that with a 
strong TGF-β stimulation, the pre-bound receptors are capable of sustaining 
the signaling response for half of an hour and tiding it to the next stimulus. 
Incidentally, this optimal gap period is approximately the time to reach 
maximum Smad2 phosphorylation and nuclear accumulation of Smad2 after 
TGF-β stimulation [204]. Therefore, there is a time-delay in the TGF-β 
signaling system, which may be attributed to ligand-bound receptor 
endocytosis or Smad nucleocytoplasmic shuttling dynamics. Because of this 
built-in time-delay, the TGF-β signaling system can filter high frequency 
changes (short time pulsations) in ligand stimulations. Thus, combining 
mathematical modeling with guided experiments enables new discoveries in 
systems properties of TGF-β signaling that would have been difficult to reveal 
using the traditional biochemical approaches alone. The functional 
significance of pulses of TGF-β has yet to be shown in vivo, but is 
theoretically occurring within tissues, where the extracellular volume and 
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local secretion of TGF-β is extremely small in magnitude, resulting in a 
largely noisy extracellular level of TGF-β. Such noise would then be 
dampened by the delayed TGF-β response that has been observed in cell 
culture models.  
 
Quantitative analysis of transient and sustained signaling responses 
The duration of signaling responses can be critical for alerting cell fate 
decisions in response to growth factor. Previous work with PC12 cells showed 
that epidermal growth factor (EGF) induces transient activation of 
extracellular signal-regulated kinase (ERK) and results in cell proliferation, 
while sustained ERK activation triggered by nerve growth factor (NGF) leads 
to cell differentiation [227, 228]. Although some of these effects could be due 
to non-ERK dependent responses to the differing ligands, these experiments 
propose an interesting notion, where the duration of ligand stimulation can 
determine the prevailing cellular response. 
 In the case of the TGF-β signaling network, the duration of Smad 
signaling response seems to be context dependent. Experimental studies have 
shown that keratinocyte epithelial cells have sustained phospho-Smad 
responses to TGF-β, while some fibroblast and tumor cells display transient 
Smad activation [229, 230]. It was hypothesized that sustained TGF-β 
signaling may be required for growth inhibition, while transient signaling may 
cause the resistance to anti-proliferative effects of TGF-β in certain tumor 
cells [229]. However, the exact mechanism underlying the variation of Smad 
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signal duration in different cell types remains to be elucidated. Here we 
summarize the time dependent changes in the cellular responses to TGF-β.  
 
Sequestration of TGF-β receptors by endocytosis 
TGF-β signaling is initiated by the binding of TGF-β to TβRI and TβRII. 
The activation of the ligand-receptor complex is a relatively fast step in the 
TGF-β signal transduction pathway. An early study from Wrana et al. shows 
that the phosphorylation of TβRI in the receptor complex peaks at about 2 
minutes after TGF-β stimulation [231]. The signal is relayed to the activation 
of Smad proteins, which arrive at their maximal levels in about 30-60 minutes. 
The time delay between ligand receptor complex and R-Smad activation may 
due to intermediate processes, including receptor endocytosis, the recruitment 
of Smads to receptor complex and Smad activation. After 30-60 minutes, the 
phosphorylation of Smads correlates with the degree of TGF-β-receptor 
complex level, which might be due continuous nucleocytoplasmic shuttling of 
the Smads, but this shuttling fails to explain why there is a prominent delay 
following receptor activation and prior to Smad phosphorylation [74, 213].  
Although it has been shown that two main types of endocytosis mediate 
the internalization of TGF-β receptors, clathrin-dependent and clathrin-
independent [200, 232], different lines of experimental evidence display 
discrepancies in the requirement of receptor internalization for Smad 
phosphorylation. Using potassium depletion, which interferes with clathrin-
dependent internalization of receptors, pSmad2 levels are reduced in Mv1Lu 
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cells [201, 233]. On the other hand, potassium depletion or mutant dynamin 
(K44A) in L17-TβRI cells reveals that receptor trafficking is entirely 
dispensable for TGF-β signaling to occur [200, 234]. Even though there is 
little debate about whether the TGF-β receptors undergo endocytosis, the 
precise role of receptor endocytosis in signaling remains controversial [200]. 
Several lines of evidence support a positive role of endocytosis on R-Smad 
phosphorylation [201, 233, 235, 236], while there are several reports 
describing Smad activation immediately at the cell surface without need of 
receptor endocytosis [234, 237, 238]. The disagreement among these studies 
could be attributed to different cell types and experimental systems. Despite 
the variable effects of receptor endocytosis on Smad phosphorylation, 
activation of non-Smad signaling pathways by TGF-β appears to require 
receptor internalization [238, 239].  
To understand the role of receptor endocytosis on TGF-β signaling, 
mathematical models were established by focusing on TGF-β receptor 
endocytosis. Vilar et al. developed a concise model for TGF-β receptor 
trafficking and the ligand-receptor interactions. This model predicts that the 
duration of signaling activity is determined by the ratio of the constitutive to 
the ligand-induced degradation rate of the receptors, termed the “constitutive-
to-induced degradation ratio” (CIR). Model analyses suggest that signal 
activity is transient with a low CIR, while sustained signal response is 
observed with a high CIR. The model has some assumptions including: (1) 
TGF-β signaling activity is proportional to the level of ligand-receptor 
complexes in the internalized endosomes, and (2) Ligand-receptor complexes 
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between type I and type II receptors have the same constitutive degradation 
rate. In addition, the model lumps the processes including non-clathrin 
dependent internalization, recycling and the degradation of the receptors into 
one reaction as “the ligand-induced receptor degradation from plasma 
membrane”. Thus, CIR defined in Vilar’s model is not directly determined by 
the ratio of the reaction rate constants for constitutive and ligand-induced 
degradations. Instead, it refers to the balance of the overall effect of the 
combined processes of the two branches of receptor degradation machinery.  
Subsequently, a mathematical model developed by Zi and Klipp includes 
two major types of TGF-β receptor endocytosis, Smad activation and Smad 
nuclearcytolasmic shuttling [217]. Similar as Vilar’s model, the extended 
model assumes that Smad activation is proportional to the ligand-receptor 
complex in early endosomes. The model simulations using different sets of 
parameter values suggest that Smad activation is regulated by the balance 
between clathrin dependent endocytosis (kiEE) and caveolar/lipid-raft 
mediated (clathrin-independent) endocytosis (kiCave). If clathrin-dependent 
internalization is dominant (kiEE >> kiCave), Smad activation becomes a 
sustained response. On the other hand, if clathrin-independent endocytosis is 
overwhelming (kiCave >> kiEE), Smad activation displays a transient response. 
Interestingly, the simulation results suggest that changing the balance between 
the two branches of endocytosis has relatively little effect on the early Smad 
signal, and has larger effect in reshaping long term Smad activity. This 
hypothesis might explain the variations among experimental observations 
about the impact of inhibiting TGF-β receptor endocytosis on TGF-β 
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signaling responses, where the different model systems may have different 
ratio of clathrin-dependent to clathrin-independent endocytosis. Thus, in a cell 
line with similar rates of clathrin-dependent and clathrin-independent 
endocysis, an inhibition of clathrin-dependent will make clathrin-independent 
endocysis (ligand-induced receptor degradation) dominant and result in a 
reduction in Smad activity. In other cell types, if the clathrin-dependent 
endocytosis is overwhelmed by clathrin-independent endocytosis, inhibiting 
clathrin-dependent internalization will not shift the balance between these two 
endocytosis branches and should result in little effect on the perturbation of 
signaling responses. Moreover, the inhibitors of endocytosis used in previous 
experimental studies may not be very specific and could have some off target 
effects. In the future, a systems biology approach can be useful to clarify this 
issue by combining mathematical models with quantitative experimental data 
of receptors and Smad kinetics.  
 
Quantitative analysis of the dynamics of Smad nuclear import and export 
A prominent feature of TGF-β signaling is the continuous shuttling of 
Smads in and out the nucleus, in both treated and untreated cells [74, 240]. 
Ligand-induced nuclear accumulation of R-Smad and Co-Smad is relatively 
slow and peaks at ~45 min after TGF-β exposure. Ligand-induced Smad 
shuttling dynamics is considered to be a prevailing mechanism for Smads to 
continuously monitor receptor activity [74, 240]. Different mechanisms have 
been invoked to account for Smad nucleocytoplasmic shuttling dynamics. 
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Mathematical modeling analysis has been instrumental in differentiating 
various hypotheses [155]. Clarke et al. [206] was the first to publish a kinetic 
model of Smad signaling dynamics. The simple kinetic model includes R-
Smad phosphorylation/dephosphorylaton, heterodimerization with Smad4, 
and nucleocytoplasmic shuttling steps. Analyzing the existing data with this 
model led to several novel hypotheses for Smad nuclear accumulation during 
TGF-β signaling. Through parameter sensitivity analysis, Clarke et al. posited 
that (1) the balance between the rates of R-Smad phosphorylation in the 
cytoplasm and phospho-R-Smad dephosphorylation in the nucleus determines 
Smad nuclear accumulation. (2) Smad homo- or hetero-oligomerization could 
protect the phospho-R-Smads from rapid dephosphorylation and therefore 
promote Smad nuclear accumulation. (3) Nuclear retention factors alone are 
insufficient for induction of Smad nuclear accumulation. Schmierer et al. 
investigated the relationship between receptor activation and Smad shuttling 
dynamics using a combined mathematical modeling and systematic 
experiment approach [213]. Two competing models were developed based on 
different assumptions of the Smad import mechanism. The retention/enhanced 
complex import (RECI) model assumes Smad complexes to be imported at a 
faster rate than the monomeric species, while the retention only (RO) model 
sets identical import rates for both Smad complexes and monomeric species 
but only allows nuclear retention of complexes. The two competing models 
were simultaneously fit to four sets of kinetic empirical data. The result of 
comparative analysis shows that RECl is clearly a more accurate model. 
Moreover, the RECl model also shows excellent agreement with fluorescence 
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recovery after photobleaching (FRAP) data of GFP-Smad2 that were not used 
to construct the model. The FRAP experiment was used to infer the shuttling 
of GFP-Smad2 between nucleus and cytoplasmic compartments. Therefore, 
quantitative analysis of Smad shuttling led to the notion that the Smad 
complex must have a faster nuclear import rate and that the phosphatase(s) 
that deactivate R-Smads likely resides in the nucleus. A novel insight that 
comes out of the modeling analysis is that time-delayed coupling between 
receptor activity and Smad nuclear accumulation could function as a low-pass 
filter to dampen the noise in receptor activity [213, 241].  
 
Negative feedbacks in TGF-β signaling  
Negative feedback in a signal transduction cascade is one of the major 
mechanisms for desensitization of sustained ligand stimulation and generation 
of transient, sometimes oscillating signaling outputs [242]. Even though 
transient or oscillatory responses associated with sustained TGF-β exposure 
are not ubiquitous, potential negative feedback motifs have been identified. 
The most well characterized example is Smad7, a TGF-β-inducible early 
response gene [243, 244]. Smad7 antagonizes TGF-β signaling through 
multiple mechanisms, both in the cytosol and the nucleus. Since Smad7 can 
bind the TGF-β receptors, but lacks the SXSS motif commonly found in R-
Smads, it has been proposed that Smad7 is likely to be a pseudo substrate and 
a competitive inhibitor of R-Smads [243, 244]. Owing to its ability to form 
stable complexes with the TGF-β receptors and PP1 phosphatase [245] or the 
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ubiquitination E3 ligase Smurf1 and Smurf2 [246], Smad7 serves as an 
adapter to mediate inactivation of TGF-β receptors through dephosphorylation 
or ubiquitin-proteasomal degradation. Besides targeting receptors for 
inactivation, Smad7 also appears to be involved in repressing TGF-β-
dependent transcription through either disruption of R-Smad/Co-Smad/DNA 
complexes or recruitment of histone deacetylases [247]. Regardless of the 
exact biochemical mechanisms of Smad7, the induction of Smad7 by TGF-β 
and its function as an antagonist for TGF-β signaling are very compelling. A 
key question is, “what is the strength of this feedback and to what degree does 
it impact TGF-β signal transduction.” Melke at al. analyzed a more 
comprehensive model of TGF-β/Smad signaling in endothelial cells that 
included canonical Smad signaling. They found that negative feedback 
through Smad7 was important for terminating signaling and for conferring 
global robustness to the TGF-β pathway [212]. TMEPAI is another antagonist 
of TGF-β signaling and is transcriptionally induced by ligand exposure [248]. 
TMEPAI possesses both transmembrane and Smad interacting domain (SIM). 
The inhibition of TGF-β signaling can be attributed to sequestration of both 
unphosphorylation and phosphorylated R-Smads from interacting with the 
receptors or Smad4 [248]. While inhibition of TGF-β signaling by Smad7 and 
TMEPAI predominantly occurs in the early step of signaling propagation, the 
negative feedback loop that involves SnoN appears to target the downstream 
signaling cascade at the chromatin level. SnoN and its relative Ski are both 
transcriptional co-repressors of the Smad signaling complex [249, 250]. In the 
early phase of TGF-β stimulation, SnoN is destabilized by association with 
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activated R-Smads and ubiquitin E3 ligases such as Arkadia [251-254]. 
Degradation of SnoN/Ski unleashes the full activity of the Smad complex, 
resulting in the transcriptional activation of target genes. SnoN is one of the 
TGF-β inducible genes and the elevated SnoN restrains the activity of Smad 
complexes [251]. Therefore, there are at least three negative feedback loops 
associated with TGF-β signaling. All of these are initiated by transcriptional 
induction of the antagonist, although spatial and temporal variations exist 
among them.  
 
Are there oscillations in TGF-β signaling responses? 
Oscillations of signaling responses have been observed in some pathways 
with negative feedbacks, for example, NF-κB, p53 and Erk systems [225, 255, 
256]. Modeling analyses have shown that biochemical oscillations can occur 
if four general requirements are satisfied: negative feedback, time delay, 
nonlinearity of the reaction kinetics, and tightly controlled timescales of 
opposing chemical reactions [257]. Since different negative feedbacks have 
been proposed for regulating TGF-β signaling [258], theoretically, it is 
possible to generate oscillating responses in the TGF-β network. Recent 
modeling analyses by extensive sampling of parameter space show that 
oscillating Smad signaling can appear by fine-tuning only a few parameters 
related to negative feedback (e.g. Smad7) [210, 216]. However, it is still an 
open question about whether there are oscillations in TGF-β network because 
no oscillations of TGF-β signaling have yet been observed in cells. One 
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reason could be that the negative feedback regulations of TGF-β network may 
not be strong enough at the endogenous level. Moreover, the time-delay 
between negative feedback and Smad activation might not be coupled in a 
proper time scale at in vivo conditions. Last but not least, cell signaling often 
results in heterogeneous responses within single cells. Averaging signaling 
dynamics at cell population levels can mask dynamic signaling mechanisms 
within individual cells [259]. Oscillation responses may appear upon 
investigation at the single cell level in a variety of cell lines and culture 
conditions.  
 
 
Modeling cell context specific TGF-β signaling 
It has been long recognized that the cellular responses triggered by TGF-β 
are often cell type specific and stimulation specific [260]. For example, TGF-
β is a potent inhibitor of normal epithelial cell proliferation but acts to 
stimulate fibroblast growth [260]. Even in the same cell type, TGF-β can 
produce opposite proliferation effects depending on the presence of other 
growth factors. In the presence of PDGF, TGF-β stimulates growth of Myc-1 
cells, and in the presence of EGF, TGF-β inhibits growth of the exact same 
cells [260]. The exact molecular mechanisms underlying these contradictory 
cellular responses remain largely elusive. One possible explanation to account 
for these observations is that the pathways activated by TGF-β vary among 
different cell types and are restrained by cross-talk with other signaling 
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pathways. Even though TGF-β signals through Smad2 and Smad3 in most cell 
types through ALK-5, in endothelial and hepatic stellate cells TGF-β induces 
phosphorylation of both Smad1/5 and Smad2 via ALK-1 and ALK-5, 
respectively [212, 226, 261]. Based on this evidence, Melke et al. developed a 
mathematical model for the TGF-β pathway in endothelial cells, taking 
parallel activation of ALK1 and ALK5 into consideration. Their model 
recapitulates the kinetics of the experimental data and correctly predicts the 
behavior in experiments where the system is perturbed [212]. This study 
highlights a need to develop mathematical modeling tailored to a specific 
biological context in order to understand the multifunctional nature of TGF-β 
signaling.  
 
Outlook and concluding remarks 
TGF-β signaling is spatiotemporally regulated in at least three 
compartments (extracellular, cytosol and nucleus). Quantitative analysis of the 
TGF-β signaling pathway is still very much in its infancy. At present, 
modeling efforts have been focused on the canonical TGF-β signaling 
cascade. As TGF-β signals through both canonical and noncanonical 
pathways, it is imperative to develop mathematical models that comprise both 
pathways in order to accurately predict overall TGF-β biology. Since the 
noncanonical pathway is often cell type dependent and operates in the context 
of other signaling networks, it will be a major challenge to develop such 
models. Another challenge is to understand the quantitative coupling between 
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Smad signaling kinetics and gene expression profiles. Most of the 
mathematical models developed so far assume that the dynamics of Smad2 
and Smad3 phosphorylation is similar and indistinguishable. However, the 
biological functions of Smad2 and Smad3 are clearly different, based on 
mouse knockout studies and DNA microarray analysis [262, 263]. The 
abundance of Smad2 and Smad3 varies significantly in different cell types and 
the ratio of Smad2 and Smad3 influences the resulting cellular response to 
TGF-β stimulation [206, 264]. Future modeling efforts need to consider how 
to model the R-Smads separately. Finally, given the emerging role of TGF-β 
type III receptor in modulating TGF-β signaling [265], it would be interesting 
to quantitatively assess their contributions to the signaling dynamics. As more 
quantitative TGF-β signaling data becomes readily accessible, we anticipate 
that the innovative systems biology approach to study TGF-β/Smad signaling 
will fundamentally advance our knowledge in this major signaling network.  
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CHAPTER VI 
 
Analysis of Ligand Dependent Nuclear Accumulation of Smads in 
TGF-beta Signaling 
 
ABSTRACT 
The growth inhibition of dividing cells and most of the transcriptional 
responses upon TGF-beta treatment depend on the Smad2, Smad3, and Smad4 
transcription factors. These proteins shuttle continuously between the 
cytoplasm and the nucleus, transmitting the ligand status of the TGF-beta 
receptors to the nuclear transcription machinery. In the absence of TGF-beta 
ligand, Smads 2/3/4 reside predominantly in the cytoplasm. Following ligand 
binding to the TGF-beta receptors, the dynamic equilibrium of shuttling 
Smads 2/3/4 shifts towards a predominantly nuclear state, where a high 
concentration of these transcription factors drives transcriptional activation 
and repression of genes required for proper cellular response. Here, we 
describe live-cell imaging and immunofluorescence microscopy methods for 
tracking Smads subcellular localization in response to TGF-beta and 
leptomycin B treatment.  In addition, a method of fractionating nuclear and 
cytoplasmic proteins used to confirm the imaging results was presented.  Our 
results support the notion that the R-Smad shuttling mechanism is distinct 
from Co-Smad.    
 
142
INTRODUCTION 
 
Transforming Growth Factor Beta (TGF-beta) is a cytokine that can cause 
several distinct cellular responses, including growth inhibition, apoptosis, and 
differentiation (For Review [69]).The active form of the TGF-beta ligand 
binds as a dimer to the TGF-beta receptors on the plasma membrane of target 
cells, thus carrying a signal from one cell to another (For Review on ligand-
receptor interactions:[132]). Type I and Type II TGF-beta receptors (TBRI 
and TBRII, respectively) are serine/threonine kinases that transmit the signal 
across the plasma membrane [69]. TGF-beta binding to TBRII induces hetero-
oligomerization of TBRII with TBRI [69]. The receptor oligomerization 
initiates a protein phosphorylation cascade, eventually propagating the signal 
into the nucleus. This cascade begins when TBRII phosphorylates TBRI, 
resulting in activation of TBRI’s kinase activity [69]. Active TBRI then 
phosphorylates receptor regulated Smad proteins also known as R-Smads 
(Smad2 and Smad3) [70]. These phosphorylated Smad2/3 proteins homo-
oligomerize into protein complexes, as well as hetero-oligomerize with Smad4 
or Co-Smad [72, 73]. Oligomerization of Smads 2/3/4 correlates with nuclear 
accumulation of these proteins [71]. Smads 2/3/4 are transcription factors that 
activate the transcription of p21 and p15, which cause cell cycle arrest in the 
G1 phase of the cell cycle, as well as repress transcription of growth 
promoting genes such as c-myc and CDC25A [69]. It is through 
transcriptional regulation of these genes, and possibly others yet to be 
identified, that Smad nuclear accumulation leads to cytostatic responses.   
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Nucleocytoplasmic shuttling of signaling proteins is a common theme 
shared by many cellular signaling pathways.  Smads are constantly cycling in 
and out of nucleus even in the absence of ligand stimulation [74, 266].   The 
Smad nuclear export rates exceed their import rates in the basal state 
consequently both Smad2/Smad3 and Smad4 are predominantly localized to 
the cytosol [207, 267].  Ligand stimulation decreases the export rates of 
Smad4 without significantly affecting the import rates resulting in nuclear 
accumulation of Smad4 [207].  Similar mechanism may also account for R-
Smad nuclear accumulation although nuclear import and export mechanism of 
R-Smad and Smad4 appears to be distinct.  Earlier studies have shown that 
Smad3 but not Smad2 or Smad4 can directly interact with importin β1 and 
interaction may be important for nuclear translocation of Smad3 [268-270]. 
Subsequent studies suggest that nuclear import of Smad2 and Smad3 can also 
occur through direct binding of Smad2/3 to nucleoporins Nup214 and Nup153 
[266].  Thus, both importin β-dependent and importin β-independent pathways 
are involved in trafficking R-Smad into nucleus.   For shuttling R-Smad out of 
the nucleus, exportin 4 has been implicated as the export factor for Smad3 and 
most likely for Smad2 as well [271].  Unlike R-Smad, nuclear import of 
Smad4 likely relies on importin 7/8 or importin alpha [270, 272] while Smad4 
nuclear export occurs by binding to the nuclear export factor CRM1 as 
treatment of the specific small molecule inhibitor Leptomycin B (LMB), 
which targets CRM1, is sufficient to drive nuclear accumulation of Smad4 but 
not Smad2 or Smad3 [273-275].  Two nuclear export signals have been 
identified in Smad4 and mutation of these signals causes Smad4 to 
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exclusively localize to nucleus [269, 273, 274].  Despite all these advances, a 
number of outstanding questions still remain unanswered.  For example, how 
is the phosphorylated R-Smad induced by TGF-beta treatment translocated to 
the nucleus?   Is the import rate for the phosphorylated Smad2/3 higher than 
the unphosphorylated Smad2/3?  How Smad homo- or heteroligomerization 
regulates Smad nuclear accumulation? Can the rate of Smad import or export 
be re-adjusted intrinsically or in response to signaling cross-talk?  Here we 
described some of the key methods that can be used to determine the 
trafficking mechanisms of Smad in the mammalian system.  
 
MATERIALS 
 Cell Culture 
1. Dulbecco’s Modified Eagle Medium (DMEM) (GIBCO, Invitrogen) 
2. DMEM lacking phenol red (GIBCO, Invitrogen 31053-036) 
3. GlutaMAX L-Glutamine Supplement (GIBCO, Invitrogen 35050-061) 
4. Dulbecco’s Phosphate Buffered Saline (D-PBS) (GIBCO, Invitrogen 
14190-136) 
5. 100 X Penicillin G Solution (Solid Penicillin G from Sigma in distilled 
water to 10,000 U/ml) 
6. Streptamycin Sulfate solution (Solid streptomycin sulfate from Sigma 
in distilled water to 10,000 U/ml) 
Live Cell Treatment 
1. Leptomycin B, 500 µg in Absolute Ethanol (LC Laboratories L-6100) 
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2. Transforming Growth Factor Beta1 (TGF-beta1) (R and D Systems 
240-B-010) 
Cellular Fractionation 
1. Hypotonic Lysis Buffer (10 mM Tris Base HCL, 10 mM KCl, 1.5 mM 
MgCl2, 1 mM Sodium Orthovanadate, 0.2 mM 
phenylmethanesulphonylfluoride, 1mM DTT) 
2. RIPA buffer (150 mM NaCl, 1 % v/v Triton X 100, 1 % w/v sodium 
deoxycholic acid, 0.1 % w/v sodium dodecyl sulfate, 25 mM Tris Base 
HCL, 1 mM ethylenediaminetetraacetic acid, 0.2 mM 
phenylmethanesulphonylfluoride, 1 mM Sodium Orthovanadate, 1 
mM DTT, 25 mM B-glycerophosphate, 25 mM NaF) 
3. Salt Balancing Solution (10 % v/v Triton X 100, 1 M NaCl, 100 mM 
B-glycerophosphate, 100 mM NaF) 
4. Cell Lifter (Costar, Corning 3008) 
5. Dounce Homogenizer with 1 ml volume (Wheaton) 
6. Ponceau S Staining Solution (0.5 g Ponceau S Dye, 5 % Glacial Acetic 
Acid to 100 ml with deionized water) 
7. Protogel 30 % Acrylamide/Bisacrylamide Solution (National 
Diagnostics, EC-890) 
8. Protogel 4 X Resolving Gel Buffer (National Diagnostics, EC-892) 
9. Protogel Stacking Gel Buffer (National Diagnostics, EC-893) 
10. 10 % Sodium Dodecyl Sulfate Solution (10% w/v SDS in distilled 
water) 
11. Mouse anti-Smad1/2/3 antibody (Santa Cruz Biotechnology SC-7960) 
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12. Mouse anti-Lamin A/C antibody (Santa Cruz Biotechnology SC-7292) 
13. Mouse anti-betaActin antibody (AbCam Ab8226) 
14. Horse Radish Peroxidase conjugated Sheep anti-mouse antibody (GE 
Healthcare NA931-1ML) 
15. SuperSignal West Dura Extended Duration Substrate 
chemiluminesence kit (Pierce Biotechnology 34076) 
16. Protran Nitrocellulose Membrane (Whatman 104024 BA83) 
17. Whatman Chromatography Paper (Whatman 3030-917) 
18. Semi-dry transfer apparatus (Hoefer TE70) 
19. BCA protein assay kit (Thermo 23225) 
20. Spectra broad ranged multicolor protein ladder (Fermentas SM184) 
21. Powerwave X Scanning Spectrophotometer Plate Reader (Bio-Tek) 
22. 4 X SDS-Gel Loading Buffer (to Make 10 ml: 8 mg Bromophenol 
Blue, 1 ml 0.5 M EDTA, 40 mM DTT, 4 ml 100% glycerol, 0.8 g 
SDS, 2 mL 1 M Tris Base pH 6.8, to 10 ml with deionized water) 
23. Transfer Buffer (5.8 g Glycine, 11.6 g Tris Base, 0.72 g Sodium 
Dodecyl Sulfate, 400 ml Methanol, to 2 L with deionized water) 
24. Tris Buffered Saline supplemented with Tween-20 detergent (TBS-t) 
(8.8 g NaCl, 0.2 g KCl, 3 g Tris Base, 1 ml Tween 20, pH 7.4 to 1L 
with deionized water) 
25. Western Blot Film (ISC BioExpress F-9023-8X10) 
 
Immunofluorescence 
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1. Poly-D-Lysine Hydrobromide Solution (1 mg/ml Poly-D-Lysine 
Hydrobromide (Sigma P7405-5MG), 23.5 mM Sodium Tetraborate, 50 
mM Boric Acid, pH to 8.5) 
2. Round Glass Coverslips (Fisherbrand 12-546 18CIR-2) 
3. Glass Slides (VWR 48312-003) 
4. Rabbit anti-Smad2 antibody (Zymed Laboratories 51-1300) 
5. Mouse anti-Smad4 antibody (Santa Cruz Biotechnology SC 7966) 
6. Goat anti-Mouse Alexafluor488 conjugated antibody (Molecular Probes, 
Invitrogen A11001) 
7. Goat anti-Rabbit AlexaFluor555 conjugated antibody (Molecular Probes, 
Invitrogen A21428) 
8. Normal Goat Serum (Invitrogen PCN5000) 
9. 3.7 % Paraformaldehyde solution (Made from dilution of 16 % solution in 
deionized water, Electron Microscopy Sciences 15710) 
10. 10 mg/ml Hoescht 33258 Solution in deionized water (made from solid, 
Invitrogen H21491) 
11. Clear Nail Polish (Sally Hansen ‘Hard as Nails’ 2103) 
12. Nikon ECLIPSE TE2000 Inverted Fluorescence Microscope equipped 
with the following; excitation filters: 360/40 Hoescht 55258, 490/20 
AlexaFluor488, 555/28 AlexaFluor555, 470/30 GFP, 492/18 YFP. 
Emission Filters: 457/50 Hoescht 33258, 528/38 AlexaFluor488, 617/73 
AlexaFluor555, 510/30 GFP, 535/30 YFP. Camera: COOLSNAP ES. 
Software: Metamorph Premier Imaging System.  
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Live Cell Imaging 
1. GFP-Smad4 HaCaT Cells was created by retroviral mediated gene 
transfer.  Briefly, pMX-GFP-Smad4, a retroviral expression vector 
described previously [275], was transfected into the amphotrophic 
packaging cell line ϕNX 293T cells using Mirus (Mirus Bio, Madison, 
WI).  Infection and selection of GFP positive stable cell lines using FACS 
sorting were performed as described [276].  Similar procedure was used to 
create YFP-Smad2 HaCaT Cells except the expression vector used was 
pREX-YFP-Smad2-IRES-Hygromycin.    
2. Glass Bottom 35 mm Petridishes (Mat Tek Corporation P35G-0-7-C) 
 
METHODS 
 
Cellular fractionation of cytoplasm and nuclear proteins 
1. Using the methods of cellular fractionation and western blot analysis, we 
find that both TGF-beta and Leptomycin B treatment of cells is sufficient 
to increase the fraction of total cellular Smad4 protein located in the 
nucleus. This is not observed to be the case for either Smad2 or Smad3, 
where only TGF-beta treatment was sufficient to increase the fraction of 
total cellular Smad2/3 protein in the nucleus (Figure 6.1 D).  
2. 4 X 10 cm tissue culture Petri dishes were seeded with 10 ml and 2 x 106 
adherent HaCaT cells and allowed to grow for 24 hours at 37 ˚C in a 5 % 
CO2 atmosphere (See Note 1) Two plates were treated for 30 minutes with 
20 ng/ml LMB prior to addition of 100 pM TGF-beta1 to one of these 
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Figure 6.1 Measuring Endogenous Smad Nuclear Accumulation. A) Nuclear accumulation of Smad2 
and 4 is measured by immunofluorescence and quantified by densitometry in HaCaT cells as a function of 
either ligand stimulation or leptomycin B treatment (B and C). D) Alternatively, cellular fractionation and 
western blotting can be used to quantify the relative accumulation of Smads in the nucleus.  
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plates and to one of two plates not treated with LMB. Cells were treated 
with TGF-beta1 for one hour. Total volume of media in all plates is 10 ml. 
3. Each 10 cm plate containing 2 x 106 adherent HaCaT cells are rinsed (See 
Note 2) one time with 10 ml 4 ˚C Dulbecco’s Phosphate Buffered Saline 
(D-PBS). D-PBS is removed by titling the plate vertically at an 80 degree 
angle in a bucket full with ice for one minute and aspirating all liquid from 
the bottom corner of the plate using a vacuum trap and a glass Pasteur 
pipette. 10 ml of 4 ˚C hypotonic lysis buffer is then added to the plate, 
which is then incubated horizontally on ice for 15 minutes. During this 
incubation, cells will swell, providing an easier lysis in the following steps 
(See Note 3) All hypotonic lysis buffer is removed in the same manner as 
stated above. 70 µl of 4 ˚C hypotonic lysis buffer supplemented with 0.4 
% TX100 is added to each plate. With the plate tilted at an 80 degree angle 
in a bucket of ice, cells are scraped using a cell lifter, and all cells are 
pushed towards the pooling liquid in the bottom end of the tilted plate.  
4. Scraped cells in lysis buffer are briefly homogenized by pipetting up and 
down the pooled liquid in the plate, being careful not to introduce air 
bubbles (See Note 4). The mixture of buffer and cells is then transferred to 
a 1.7 ml Eppendorf tube on ice, and incubated at 4 ˚C for 15 minutes. 
5. Using a 200 µl pipette, cells are further homogenized by pipetting up and 
down without introducing air bubbles. Cells and buffer are transferred to a 
clean 4 ˚C 1 ml Dounce homogenizer, and the ‘loose fit’ plunger is raised 
and lowered 60 times. The plunger is removed and the liquid is allowed to 
collect in the bottom of the homogenizer for 30 seconds. 1-2 µl of liquid 
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homogenate is removed, and placed on a microscope slide and a cover-slip 
is applied to prevent evaporation. The homogenate is confirmed to be 
composed of nuclei, which look wrinkled oval and dark, and debris, which 
is the result of plasma membrane breakage. There should be no presence 
of in-tact cells at this point. However, if there are still 5-10 % unbroken 
cells one may apply the plunger again and homogenize the cells 40-60 
more times before proceeding to step 5 (See Notes 5 and 6) 
6. Homogenate is transferred to a fresh 4 ˚C 1.7 ml eppendorf tube and spun 
for 5 minutes at 800 rcf and 4 ˚C. A small pellet forms at the end of the 
tube, and the supernatant contains plasma membrane components and 
cytoplasm contents. Most of the supernatant is removed by pipetting and 
labeled as cytoplasmic fraction, and care is taken not to disturb the pellet 
(See Note 7). Cytoplasmic fractions are balanced for salt, detergent, and 
phosphatase inhibitors by addition of 20 µl salt balancing buffer.   
7. The last bit of supernatant is removed and discarded. The nuclear pellet is 
rinsed one time by addition of 100 µl of 4 ˚C hypotonic buffer lacking  0.4 
% TX100. The tube containing hypotonic wash buffer and nuclei is then 
spun for 5 minutes at 800 rcf and 4 ˚C (See Note 8). All liquid contents of 
the tube are removed by aspiration, being careful not to disturb the pellet 
or to scrape the inner walls of the tube. The nuclei are then lysed 
completely by addition of 70 µl of RIPA buffer followed by gentle 
flicking and inverting of the tube. These tubes are then labeled as nuclear 
fractions. 
8. Cytoplasmic and nuclear fractions are rotated for 45 minutes at 4 ˚C. 
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9. Fractions are then spun for 10 minutes at 13,200 rcf and 4 ˚C. 
Supernatants are transferred to new labeled tubes and stored on ice (See 
Note 9). 
 
Determining Protein Concentration and Performing Western Blot 
Analysis 
 
1. Protein concentration is determined using a BCA assay kit, according to 
the manufacturer’s instructions. Briefly, serial dilutions of 2.0 mg/ml 
Bovine Serum Albumin (BSA) stock solution in a 1:10 dilution of RIPA 
solution:distilled water are made to produce 1.0 mg/ml, 0.5 mg/ml, 0.25 
mg/ml standards, while a blank is made from 1:10 dilution of RIPA 
solution:distilled water alone. A 2 µl aliquot of each fraction is removed to 
make a 1:10 dilution of each unknown sample in distilled water, yielding a 
total of 20 µl of diluted unknown sample.  
2. 5 µl of each unknown and each standard are mixed with 100 µl of 1 X 
BCA Solution (50:1 mixture of solutions A and B, from the BCA kit), 
each in 1 well of a clear 96 well polyethylene plate. Plates are completely 
sealed to prevent evaporation using parafilm tape, and incubated at 37 ˚C 
for 30 minutes. 
3. The 96 well plate is read at 562 nm for absorbance using a 96 well plate 
scanning spectrophotometer. Using Excel, a spreadsheet is constructed to 
determine the mathematical relationship of BSA concentration to 
absorbance for the standards, and this relationship is used to determine the 
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concentration of the proteins in each unknown sample. The total yield in 
the cytoplasmic fraction is 150 µg in 100 µl, while the total yield in the 
nuclear fraction is 100 µg in 75 µl.  
4. For each cytoplasmic fraction, 50 µg of total protein is prepared for 
loading into a single well, while 33.3 µg of total protein is prepared for 
loading into a single well for nuclear fractions (See Note 10). Each sample 
for loading into an SDS-PAGE gel is mixed with 7 µl of 4 X SDS-loading 
buffer and incubated at 95 ˚C for 5 minutes. Tubes are inverted and liquid 
contents are briefly spun at 5000 rcf for 30 seconds. In this experiment, 2 
identical sample sets are used to make two identical gels.  
5. A 1.5 mm, 12 % polyacrylamide mini-gel polymerized with a 10 well 
comb (manufactured using SDS-PAGE Protogel reagents from National 
Diagnostics according to the manufacturer’s instruction) is loaded with 
samples and 5 µl Spectra protein ladder (Fermentas) and 10 µl of SDS-
loading buffer is added to any spare/empty wells prior to application of 
current. Each gel is run for 1 hour at 35 mA (190 V), at which time the 
bromophenol blue dye in the SDS-loading buffer runs just out of the 
bottom of the gel.  
6. Each gel is transferred in a semi dry western blot horizontal transfer unit, 
using a sandwich from cathode (bottom piece) to anode (top piece) with 
the following scheme: 3 pieces of chromatography paper, 1 piece of 
nitrocellulose paper, SDS-PAGE gel containing samples, 3 pieces of 
chromatography paper. This sandwich is assembled under 50 ml of 
transfer buffer, and removed as a sandwich and placed in the transfer 
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apparatus such that the gel is above the membrane, as proteins will be 
deposited on the nitrocellulose membrane as they move down towards the 
cathode. The sandwich is then lightly ironed with a 10 ml glass test tube to 
ensure no air bubbles are trapped between the membrane and the gel. For 
each sandwich containing one gel, for 1.5 hours at 45 mA or 7 V is 
applied to the apparatus, which is assembled as indicated by the 
manufacturer.  
7. Nitrocellulose paper is removed from the apparatus following transfer of 
proteins, and stained with 10 ml of Ponceau S Staining solution at room 
temperature for 1 minute. Staining solution is removed and the membrane 
is rinsed 5 times with 20 ml of distilled water to remove non-specific 
Ponceau S stain. Each cytoplasmic lane should have even and bright red 
staining. In contrast, far less staining should be present for each nuclear 
sample. At this point, one can make a reasonable assessment of the purity 
of the nuclear fractions by seeing whether abundant protein bands in the 
cytoplamic fraction lanes are shared in the nuclear fraction lanes.  
8. Each membrane is blocked with 10 ml of 3 % (w/v) non-fat dry milk in 
TBS-t at room temperature for 45 minutes.  
9. Blocking buffer is completely removed and discarded prior to the addition 
of 5 ml of 1:500 mouse anti-Smad1/2/3 in 3 % (w/v) non-fat dry milk in 
TBS-t to one membrane, while another solution of 1:1000 mouse anti-
Smad4 in 3 % (w/v) non-fat dry milk in TBS-t is added to the other 
membrane.  
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10. Each blot is incubated with primary antibody solution for 3 hours at room 
temperature, on a table top rocker.  
11. Membranes are washed 2 times for 2 minutes with 10 ml of TBS-t.  
12. Each membrane is then incubated with 3 ml of 1:2000 anti-mouse HRP 
conjugated secondary antibody solution in 3 % (w/v) non-fat dry milk in 
TBS-t for 50 minutes at room temperature on a table top rocker.  
13. Each membrane is rinsed with 10 ml of TBS-t, and subsequently washed 
three times with 15 ml of TBS-t for 8 minutes each wash.  
14. Membranes are removed from wash buffer and allowed to drip for 10 
seconds before being laid protein side up on a piece of clear 
plastic(SARAN wrap is sufficient, or a cut three-ringed binder sheet 
protector). To each membrane is added 200 µl of West Dura solution (a 
mixture of 100 µl solution A and 100 µl solution B) and lightly tilted in 
several directions, by hand, to ensure that this 200 µl of solution covers 
the entire membrane. Another clear plastic sheet  is laid over the protein 
side up membrane, creating a sandwich of two plastic pieces around the 
membrane, which is allow to sit for 30 seconds prior to ironing out excess 
liquid from inside the sandwich with a paper towel.  
15. Plastic/membrane sandwiches are then taped to the inside of an imaging 
cassette, and exposed with x-ray developing film in a dark room for 15 
seconds, 30 seconds, 1 minute and 5 minutes to produce varied exposures 
of the protein bands. Film is then developed using an automatic film 
developer.  
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16. This process from step 9 to step 15 is repeated with a 1:1000 dilution of 
mouse anti-Lamin A/C for one membrane, and a 1:1000 dilution of mouse 
anti-betaActin for the other membrane. Both antibody dilutions are made 
in 5 ml of 3 % (w/v) non-fat dry milk in TBS-t.  
 
 
Immunofluorescence Detection of Smad2 and Smad4 
1. Using immunofluorescent image analysis, we find that the ratio of 
cytoplasmic Smad4 to nuclear Smad4 (C:N) is 1.22 ± 0.15 in the basal 
state, 0.57 ± 0.08 when treated with TGF-beta, 0.53 ± 0.16 when treated 
with LMB, and 0.46 ± 0.08 when treated with both TGF-beta and LMB. 
Thus, either LMB or TGF-beta treatment is sufficient to drive the Smad4 
from mostly cytoplasmic (C:N>1) to mostly nuclear (C:N<1)(Figure 6.1A 
and C). This was not observed to be case for Smad2, where the ratio of 
cytoplasmic Smad2 to nuclear Smad2 (C:N) is 0.78 ± 0.06 in the basal 
state, 0.54 ± 0.12 when treated with TGF-beta, 0.73 ± 0.07 when treated 
with LMB, and 0.32 ± 0.08 when treated with both TGF-beta and LMB 
(Figure 6.1A and B). We hypothesize that to cause for the C:N < 1 in the 
absence of both TGF-beta and LMB is due to high nuclear background of 
the anti-Smad2 antibody used for immunofluorescent staining.  
2. 4 X round coverslips are placed one in each well of 4 wells in a 12 well 
plate tissue culture plate. To each well is added 1 ml of room temperature 
1 mg/ml Poly-D-lysine hydrobromide solution, and incubated 1 hr in the 
dark. Poly-D-lyisne Solution is removed and reused up to 10 times or 
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before 2 months if stored at -80 C. Each well is washed with 1 ml of 
distilled water, and allowed to air dry in a sterile cell culture hood, with 
the UV light on. After 1 hr, 200,000 cells are added to each well in 1 ml of 
DMEM supplemented with 10 % FBS, 1 X Penecillin G/Streptomycin 
Sulfate Solution, 1 X L-Glutamine Solution (See Materials). Cells are 
allowed to adhere to the coverslips and grow for 24 hours at 37 ˚C in a 5 
% CO2 atmosphere.  
3. One well is untreated, and media is exchange with fresh pre-warmed 
media. In two other wells, LMB is added at a final concentration of 20 
ng/ml for 30 minutes prior to addition of TGF-beta1 at a final 
concentration of 100 pM to one of these wells and the remaining fourth 
well. TGF-beta1 treatment lasts for one hour, at which time cells are 
harvested. 
4. All media is removed from each well by aspiration, and washed one time 
with 1 ml of PBS. 1 ml of room temperature 3.7 % paraformaldehyde 
(freshly made from 16 % stock, diluted with water), and incubated at room 
temperature for 30 minutes. Paraformaldehyde solution is removed and 
fixed cells are washed one time with 1 ml PBS.  
5. Fixed cells are blocked with 1 ml of TBS-t supplemented with 5 % (v/v) 
normal goat serum (NGS), and allowed to incubate while rocking at room 
temperature for 1 hour. All liquid is removed prior to proceeding to the 
next step. 
6. 1 ml of solution containing 1:400 dilution of Rabbit anti-Smad2 antibody 
in TBS-t supplemented with 5 % NGS is added to each well, and 
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incubated while rocking over-night (approximately 10 hours) at 4 ˚C. 
Primary anti-smad2 solution is removed and cells are washed one time for 
10 minutes at room temperature with 1 ml of PBS before proceeding to the 
next step. 
7. 1 ml of solution containing a 1:400 dilution of Mouse ant-Smad4 antibody 
in TBS-t supplemented with 5 % NGS is added to each well, and 
incubated for 4 hours while rocking at room temperature. Cells are washed 
one time with 1 ml PBS for 10 minutes at room temperature before 
proceeding to the next step.  
8. 1 ml of solution containing a 1:400 dilution of Alexa488 conjugated Goat 
anti-Mouse and 1:400 dilution of Alexa555 conjugated Goat anti-Rabbit 
antibodies in TBS-t supplemented with 5 % NGS, and incubated at 4 ˚C 
while rocking for 4 hours, wrapped in aluminum foil to completely 
prevent exposure to light. This secondary staining solution is removed, 
and cells are rinsed quickly with 1 ml of PBS, and then washed for 20 
minutes with 1 ml PBS containing 10 µg/ml Hoescht 33258, while rocking 
at room temperature without exposure to light.  
9. Cells are rinsed twice with 1 ml PBS, and mounted on slides with 8 µl of 
30 % glycerol/TBS-t solution and coverslips are secured and sealed to the 
slides with a perimeter application of clear nail polish.  
10. Cells are imaged using a Nikon microscope with a camera and metamorph 
software. Images were integrated over 5 seconds.  
 
Image Analysis for Immunofluorescence and Live Cell Imaging 
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1. For each image a ratio of the average cytoplasmic fluorescence intensity to 
the average nuclear fluorescence intensity was calculated using 
measurements made using the ImageJ program (See Note 11). 
2. Four 20 X 20 Pixel squares were used to measure four values of integrated 
density for each of five cells for each condition. Two squares were used to 
obtain the integrated density of the cytoplasm, while two squares were 
used to do the same for the nucleus of the same cell. Integrated density 
was measured using the Analyze/Measure function in ImageJ. This 
process was repeated for five total representative cells for each condition 
tested in both immunofluorescence experiments and live cell imaging 
experiments.  
3. Averages for each of the two measurements were used to calculate the 
average integrated density for both the cytoplasm and nucleus of each cell. 
Reported values for each Cytoplasmic Integrated Density: Nuclear 
Integrated Density (C:N) consisted of average C:N values from 5 cells. 
Error for C:N is reported as a single standard deviation of the 5 C:N values 
for the 5 cells. 
   
 
Live cell imaging of GFP-Smad4 and YFP-Smad2 
1. Using live cell imaging analysis, we find that the ratio of cytoplasmic 
Smad4 to nuclear Smad4 (C:N) is 1.28 ± 0.47 in the basal state, 0.60 ± 
0.15 when treated with TGF-beta, 0.43 ± 0.04 when treated with LMB, 
and 0.41 ± 0.11 when treated with both TGF-beta and LMB. Thus, both 
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LMB and TGF-beta treatment is sufficient to drive the Smad4 from mostly 
cytoplasmic (C:N>1) to mostly nuclear (C:N<1) (Figure 6.2 A and C). 
This was not observed to be case for Smad2, where the ratio of 
cytoplasmic Smad2 to nuclear Smad2 (C:N) is 1.29 ± 0.15 in the basal 
state, 0.66 ± 0.10 when treated with TGF-beta, 1.68 ± 0.28 when treated 
with LMB, and 0.65 ± 0.16 when treated with both TGF-beta and LMB 
(Figure 6.2 A and B). Thus, our live cell imaging data supports our 
findings for endogenous Smad4 and Smad2 using immunofluorescence 
image analysis.  
2. For both GFP-Smad4 and YFP-Smad2 HaCaT cells, 200,000 cells in 1 ml 
are added to 3.5 mm glass bottom Mat-tek Petri dishes and allowed to 
settle for 24 hours. 
3. For each of the two cell lines 4 X 3.5 mm plates were prepared, where one 
plate was used as a control and media was exchange for 1 ml of 
prewarmed DMEM media lacking phenol red and supplemented with 10 
% FBS, 1 % penicillin/streptomycin, and 1 % l-glutamine solution (refered 
to as media from here on). To another plate, media was exchanged with 1 
ml prewarmed media supplemented with 100 pM TGF-B1. Two more 
plates were prepared the same way but both using media supplemented 
with leptomycin B at a final concentration of 2 ng/ml. Thus, we are testing 
two variables independently. Cells are treated for 1 hour prior to imaging. 
4. GFP-Smad4 cells were imaged using the same methods as for 
AlexaFluor488, stated above. YFP-Smad2 cells were imaged using a 
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Figure 6.2 Live Cell Quantification of Smad Nucleo-Cytoplasmic Shuttling. A)  Stable HaCaT cell 
lines expressing either GFP-Smad4 or YFP-Smad2 were used to visualize nuclear accumulation upon 
either ligand stimulation or leptomycin B treatment. Quantification of individual cells is displayed in B 
and C.  
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492/18 band pass excitation filter and a 535/30 band pass emission filter. 
For both, images were integrations of 3 seconds.  
5. Images were processed using ImageJ software, as stated above for 
immunofluorescence data.  
 
        
 
NOTES 
 
1. Cells prior to treatment should be fully spread out and 80% confluent. If 
too many cells are seeded at too high a density, clumps of cells will form 
in subsequent steps and lead to uneven lysing.  
2. The term ‘rinse’ is used here to refer to brief addition, mixing, and 
removal of solutions. In contrast, the term ‘wash’ refers to the addition, 
timed incubation while mixing on a rocker, and removal of solutions.  
3. The rate of cell swelling is not constant over different cell types, and the 
time of this incubation will have to be adjuted accordingly. 
4. If cells are clumped together after this point, the final fraction of nuclear 
lysate will be partially contaminated with cytoplasm, due to incomplete 
lysis of plasma membrane prior to separation of nuclei by centrifugation. 
5. If there are significant amounts of clumps of unbroken cells at this point, 
one may raise the amount in the hypotonic lysis buffer by adding an 
additional 30 µl, but this will dilute cytoplasmic fraction protein 
concentration. Alternatively, one may trypsinize cells at harvest, separate 
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cells from trypsin by centrifugation, wash cells 1 time with 1 ml D-PBS, 
separate cells again by centrifugation, and resuspend cells in hypotonic 
lysis buffer. This trypsinization step is in place of Steps 1 and 2.  
6. When cells are scraped and transferred to an Eppendorf tube on ice, they 
will settle to the bottom of the tube within 5 minutes. However, when 
plasma membranes are disrupted and nuclei are released, nuclei will not 
settle in less than an hour, and no pellet will form by gravity.  
7.  If one desires to remove the plasma membrane component of this 
fraction, one may spin 13,200 rcf for 10 min, and separate the cytoplasmic 
supernatant from the plasma membrane pellet, but this is not done in our 
procedure. 
8.  If the nuclear pellet is washed with a greater volume or more times than 
once with hypotonic buffer, then nuclei with adsorbe to the inner walls of 
the eppendorf tube, and no pellet will form during separation of nuclei by 
centrifugation. However, this will not influence the rest of the procedure, 
as all liquid can be removed and RIPA buffer added to elute nuclei from 
the walls at the same time as causing complete lysis.  
9.  From here on the ‘cytoplasm’ fraction will refer to the fraction containing 
cytoplasmic proteins as well as plasma membrane proteins.  
10. We have determined that under these conditions in HaCaT cells the total 
protein yield in the nuclear fraction is two-thirds that of the cytoplasmic 
fraction, allowing us accurately load equal ratios of cytoplasm and nuclear 
fractions. Thus, a different cell line may have a different ratio of total 
protein in the cytoplasm/ plasma membrane relative to the nuclei, and that 
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ratio will have to be determined experimentally based on the total yield of 
protein in these fractions over several experiments.  
11. Rasband, W.S., ImageJ, National Institutes of Health, Bethesda, Maryland, 
USA, http://rsb.info.nih.gov/ij/, 1997-2004.  
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CHAPTER VII 
 
Conclusions and Future Directions 
 
DISCUSSION 
 
Understanding How TGF-Beta Causes Cellular Spreading 
 In Chapter III, I showed that TGF-Beta stimulation results in cellular 
spreading and that cellular spreading results in MEK1 activation. However, it 
is not yet clear what biochemical mechanism drives these processes. I aim to 
identify the molecular events that both drive cellular spreading and MEK1 
activation by partially depleting cells of the cellular junction protein alpha 
catenin, which has been shown by others to lead to cellular spreading [63, 
107]. Thus, I will artificially induce weakening in cellular junctions in order to 
mimic the effect of TGF-Beta on HaCaT cells. Once junctions have been 
weakened in this manner, I will measure MEK1 activity by 
immunofluorescence. This approach should solidify our claim that cellular 
spreading governs MEK1 activity in HaCaT cells. Additionally, I plan on 
investigating whether alpha catenin is modified either in its subcellular 
localization or its protein expression level, upon stimulation of cells with 
TGF-Beta. In order to determine how weakening of cellular junctions leads to 
MEK1 activation, I will monitor the subcellular localization of both H and K-
Ras in the aforementioned experiments. My preliminary inspection of H-Ras 
subcellular localization revealed that dense cells have H-Ras at cellular 
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junctions, while spread out cells have H-Ras at a perinuclear region (data not 
shown). Thus, it is entirely possible that membrane junctions sequester and 
inactivate Ras activity at high cell density, but not low cell density. This could 
be the key biochemical mechanism behind inhibition of MEK1 activity at high 
cell density, as Ras is a known activator of MEK1 kinase activity (reviewed in 
Chapter 4).  
 
Understanding How MEK1 Activity Suppresses Cellular Turning 
In Chapter III, I also showed that MEK1 activity suppresses cellular 
turning. As this role of MEK1 has never been detailed in the literature, the 
biochemical mechanism behind this process is of great value to the cell 
migration field. As a result, I will investigate the effect of altering MEK1 
activity on cellular polarity, as I expect that migration persistence is heavily 
tied to cellular polarity. Particularly, I will look at endogenous CDC42 and 
Rac by immunofluorescence to determine if inhibition of MEK1 kinase 
activity abolishes cellular polarity. In addition, I will observe the polarity of 
CDC42 and Rho GTPase activity in live cells, as I am in the process of 
constructing stable cell lines that expresses either a GFP tagged CDC42 or a 
FRET based Rho sensor. I hypothesize that MEK1 activity stabilizes cellular 
polarity either by causing the recruitment of higher levels of CDC42 to the 
front end of migrating cells or by suppressing the development of alternative 
front end projections through the elevation of Rho GTPase activity.  
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Understanding How Migration Persistence in Individual Cells Drives 
Collective Cell Migration in Groups of Cells 
In all of my experiments on collective migration, I observe that when collective 
migration occurs, it is always accompanied by the elevated migration persistence in 
individual cells. This begs the question of which cellular behavior comes first. I 
believe that migration persistence precedes collective migration, as HaCaT cell 
colonies migrate persistently in response to MEK1 activation (Figure 3.16). 
Therefore, I have devised a way to further support my claim that a group of 
persistently migrating cells will spontaneously migrate collectively, given only one 
low resistant path. I will used mathematical modeling to simulate what I believe are 
the three simple rules that govern cells during collective migration: 1) cells are 
attached 2) cells travel towards the path of least resistance, and 3) cells migrate 
persistently. I am currently working with a more qualified programmer than myself to 
achieve this task. If we are able to use these rules to recapitulate in a mathematical 
model the cellular behavior that we see in my experiments, then we can provide 
strong evidence that these three rules are at least sufficient to give rise to spontaneous 
collective migration behavior. Thus, I aim to complete an extremely simplified model 
for collective cell migration, where individual cell migration in certain circumstances 
leads to the appearance of collective migration. In other words, individual cells 
migrate according to the same principles regardless of whether they are alone, or are 
part of a group.  
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